<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>RFT1 - AI Gene Review</title>
    <style>
        :root {
            --color-accept: #22c55e;
            --color-remove: #ef4444;
            --color-modify: #f97316;
            --color-keep-non-core: #3b82f6;
            --color-undecided: #6b7280;
            --color-new: #8b5cf6;
            --color-mark-over: #eab308;
            --bg-light: #f9fafb;
            --border-color: #e5e7eb;
            --text-muted: #6b7280;
            --text-primary: #111827;
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
            line-height: 1.6;
            color: var(--text-primary);
            background-color: #ffffff;
            padding: 2rem;
            max-width: 1400px;
            margin: 0 auto;
        }

        .header {
            border-bottom: 2px solid var(--border-color);
            padding-bottom: 1.5rem;
            margin-bottom: 2rem;
        }

        h1 {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 0.5rem;
            color: #1f2937;
        }

        .gene-info {
            display: flex;
            gap: 2rem;
            flex-wrap: wrap;
            margin-top: 1rem;
        }

        .info-item {
            display: flex;
            gap: 0.5rem;
        }

        .info-label {
            font-weight: 600;
            color: var(--text-muted);
        }

        .aliases {
            display: flex;
            gap: 0.5rem;
            flex-wrap: wrap;
        }

        .badge {
            padding: 0.25rem 0.75rem;
            border-radius: 9999px;
            font-size: 0.875rem;
            font-weight: 500;
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
        }

        .status-badge {
            padding: 0.375rem 0.875rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .status-initialized {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fde68a;
        }

        .status-in-progress {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #bfdbfe;
        }

        .status-draft {
            background-color: #fce7f3;
            color: #831843;
            border: 1px solid #fbcfe8;
        }

        .status-complete {
            background-color: #d1fae5;
            color: #065f46;
            border: 1px solid #a7f3d0;
        }

        .description-card {
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 2rem;
        }

        .description-card h2 {
            font-size: 1.25rem;
            margin-bottom: 1rem;
            color: #374151;
        }

        .section {
            margin-bottom: 2.5rem;
        }

        .section-title {
            font-size: 1.5rem;
            font-weight: 600;
            margin-bottom: 1.5rem;
            color: #1f2937;
            border-bottom: 1px solid var(--border-color);
            padding-bottom: 0.5rem;
        }

        .annotations-table {
            width: 100%;
            border-collapse: collapse;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            overflow: hidden;
        }

        .annotations-table thead {
            background-color: var(--bg-light);
        }

        .annotations-table th {
            text-align: left;
            padding: 1rem;
            font-weight: 600;
            border-bottom: 2px solid var(--border-color);
            font-size: 0.875rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
        }

        .annotations-table td {
            padding: 1rem;
            border-bottom: 1px solid var(--border-color);
        }

        .annotations-table tbody tr:hover {
            background-color: #f9fafb;
        }

        .action-badge {
            display: inline-block;
            padding: 0.375rem 0.75rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .action-accept {
            background-color: var(--color-accept);
            color: white;
        }

        .action-remove {
            background-color: var(--color-remove);
            color: white;
        }

        .action-modify {
            background-color: var(--color-modify);
            color: white;
        }

        .action-keep_as_non_core {
            background-color: var(--color-keep-non-core);
            color: white;
        }

        .action-undecided {
            background-color: var(--color-undecided);
            color: white;
        }

        .action-new {
            background-color: var(--color-new);
            color: white;
        }

        .action-mark_as_over_annotated {
            background-color: var(--color-mark-over);
            color: white;
        }

        .term-info {
            display: flex;
            flex-direction: column;
            gap: 0.25rem;
        }

        .term-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .term-label {
            font-weight: 500;
        }

        .evidence-code {
            font-family: monospace;
            background-color: var(--bg-light);
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .core-function-card {
            background-color: white;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 1rem;
        }

        .core-function-card h3 {
            font-size: 1.125rem;
            margin-bottom: 1rem;
            color: #1f2937;
        }

        .core-function-statement {
            margin-bottom: 1rem;
            padding: 0.75rem;
            background-color: var(--bg-light);
            border-left: 4px solid var(--color-accept);
            border-radius: 0.25rem;
        }

        .function-annotations {
            display: flex;
            flex-wrap: wrap;
            gap: 0.5rem;
            margin-top: 1rem;
        }

        .reference-item {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
        }

        .reference-header {
            display: flex;
            justify-content: space-between;
            align-items: start;
            margin-bottom: 0.75rem;
        }

        .reference-id {
            font-family: monospace;
            font-weight: 600;
            color: #2563eb;
        }

        .supported-by {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: #f3f4f6;
            border-left: 3px solid #3b82f6;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .supported-by-title {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .support-item {
            margin-bottom: 0.5rem;
        }

        .support-ref {
            font-weight: 500;
            color: #2563eb;
        }

        .support-text {
            color: #6b7280;
            font-style: italic;
            margin-left: 1rem;
        }

        a.term-link {
            color: #2563eb;
            text-decoration: none;
        }

        a.term-link:hover {
            text-decoration: underline;
        }

        .core-function-terms {
            margin-top: 1rem;
        }

        .function-term-group {
            margin-bottom: 1rem;
        }

        .function-term-label {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .reference-title {
            font-weight: 500;
            margin-bottom: 0.5rem;
        }

        .findings-list {
            margin-top: 1rem;
            padding-left: 1.5rem;
        }

        .finding-item {
            margin-bottom: 0.75rem;
        }

        .finding-statement {
            font-weight: 500;
            margin-bottom: 0.25rem;
        }

        .finding-text {
            color: var(--text-muted);
            font-size: 0.95rem;
            font-style: italic;
        }

        .proposed-term {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #fef3c7;
        }

        .question-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #dbeafe;
        }

        .experiment-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #f3e8ff;
        }

        .collapsible {
            cursor: pointer;
            user-select: none;
        }

        .collapsible:after {
            content: ' ‚ñº';
            font-size: 0.75rem;
        }

        .collapsible.collapsed:after {
            content: ' ‚ñ∫';
        }

        .collapse-content {
            transition: max-height 0.3s ease;
            overflow: hidden;
        }

        .collapsed + .collapse-content {
            max-height: 0;
        }

        .no-data {
            color: var(--text-muted);
            font-style: italic;
            padding: 1rem;
            text-align: center;
            background-color: var(--bg-light);
            border-radius: 0.5rem;
        }

        /* Styling for markdown section summaries with voting */
        .markdown-section summary {
            padding: 0.75rem;
            background: var(--bg-light);
            border-radius: 0.5rem;
            margin-bottom: 0.5rem;
        }

        .markdown-section summary:hover {
            background: #e5e7eb;
        }

        .markdown-section summary .vote-buttons {
            margin-left: auto;
        }

        @media print {
            body {
                padding: 1rem;
            }

            .collapsible:after {
                display: none;
            }

            .collapsed + .collapse-content {
                max-height: none !important;
            }
        }

        @media (max-width: 768px) {
            body {
                padding: 1rem;
            }

            h1 {
                font-size: 2rem;
            }

            .annotations-table {
                font-size: 0.875rem;
            }

            .annotations-table th,
            .annotations-table td {
                padding: 0.5rem;
            }
        }
    </style>
</head>
<body>
    <div class="header">
        <h1>RFT1</h1>
        <div class="gene-info">
            
            <div class="info-item">
                
                <span class="info-label">UniProt ID:</span>
                <span>
                    <a href="https://www.uniprot.org/uniprotkb/Q96AA3" target="_blank" class="term-link">
                        Q96AA3
                    </a>
                </span>
                
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Organism:</span>
                <span>Homo sapiens</span>
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Review Status:</span>
                <span class="status-badge status-in-progress">
                    IN PROGRESS
                </span>
            </div>
            
            
        </div>
        <div style="margin-top: 1rem; text-align: center;">
            <a id="feedback-form-link"
               href="#"
               target="_blank"
               style="display: inline-block; padding: 10px 20px; background-color: #4CAF50; color: white; text-decoration: none; border-radius: 5px; font-weight: 600;">
                üìù Provide Detailed Feedback
            </a>
            <script>
                // Construct the form URL with proper encoding
                // Extract organism code from the current page path (e.g., /genes/ARATH/APO1/ -> ARATH)
                const pathParts = window.location.pathname.split('/');
                const genesIndex = pathParts.indexOf('genes');
                let organism = '';
                if (genesIndex !== -1 && pathParts[genesIndex + 1]) {
                    organism = pathParts[genesIndex + 1].toUpperCase();
                }
                const geneSymbol = "RFT1";
                const speciesGene = organism + ' ' + geneSymbol;
                const formBaseUrl = 'https://docs.google.com/forms/d/e/1FAIpQLSdTot9L6GVkkZYgLQT0E8ZdAJv8RiN5ZgOVkgWNcKSbYvxxzQ/viewform';
                const entryId = '1226477767'; // Correct entry ID for Species/Gene field
                const formUrl = formBaseUrl + '?entry.' + entryId + '=' + encodeURIComponent(speciesGene);
                const feedbackLink = document.getElementById('feedback-form-link');
                feedbackLink.href = formUrl;
                // Add tooltip showing the pre-filled value
                feedbackLink.title = 'Opens form with pre-filled: ' + speciesGene;
            </script>
        </div>
    </div>

    
    <div class="description-card">
        <div style="display: flex; justify-content: space-between; align-items: center;">
            <h2>Gene Description</h2>
            <span class="vote-buttons" data-g="Q96AA3" data-a="DESCRIPTION: RFT1 encodes the Man(5)GlcNAc(2)-PP-dolichol trans..." data-r="" data-act="DESCRIPTION">
                <button class="vote-btn" data-v="up" title="Agree with this description">üëç</button>
                <button class="vote-btn" data-v="down" title="Disagree with this description">üëé</button>
            </span>
        </div>
        <p>RFT1 encodes the Man(5)GlcNAc(2)-PP-dolichol translocation protein, a multi-pass transmembrane protein of the endoplasmic reticulum that functions as a glycolipid flippase. It catalyzes the translocation of the lipid-linked oligosaccharide (LLO) intermediate M5GN2-PP-Dol from the cytosolic to the lumenal leaflet of the ER membrane, an essential step in the N-glycosylation pathway. RFT1 belongs to the MOP (multidrug/oligosaccharidyl-lipid/polysaccharide) transporter superfamily and contains approximately 12-14 transmembrane spans with both N- and C-termini facing the cytosol. The protein shows substrate selectivity for the M5 intermediate over shorter M3 intermediates. Loss-of-function mutations cause RFT1-CDG (OMIM 612015), a severe congenital disorder of glycosylation characterized by neurodevelopmental abnormalities, epilepsy, and sensorineural deafness.</p>
    </div>
    

    

    
    <div class="section">
        <h2 class="section-title">Existing Annotations Review</h2>
        <table class="annotations-table">
            <thead>
                <tr>
                    <th>GO Term</th>
                    <th>Evidence</th>
                    <th>Action</th>
                    <th>Reason</th>
                </tr>
            </thead>
            <tbody>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005789" target="_blank" class="term-link">
                                    GO:0005789
                                </a>
                            </span>
                            <span class="term-label">endoplasmic reticulum membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q96AA3" data-a="GO:0005789" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IBA annotation for ER membrane localization is strongly supported by phylogenetic inference and multiple lines of experimental evidence. Human RFT1 shares functional orthology with yeast Rft1 (PMID:18313027), and the protein localizes throughout the ER with approximately 12-14 transmembrane spans. UniProt annotates subcellular location as &#34;Endoplasmic reticulum membrane; Multi-pass membrane protein.&#34;
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> ER membrane localization is well-established as the core functional site for RFT1. The IBA annotation is consistent with direct experimental evidence from functional complementation studies and topology mapping.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/18313027" target="_blank" class="term-link">
                                        PMID:18313027
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The definition of the RFT1 defect establishes the functional conservation of the DolPP-GlcNAc(2)Man(5) translocation process in eukaryotes.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/RFT1/RFT1-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">Human RFT1 localizes throughout the ER. DeepTMHMM and experimental tagging/topology mapping indicate ~14 transmembrane spans with both N- and C-termini facing the cytosol</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0034203" target="_blank" class="term-link">
                                    GO:0034203
                                </a>
                            </span>
                            <span class="term-label">glycolipid translocation</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q96AA3" data-a="GO:0034203" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IBA annotation for glycolipid translocation accurately captures the core biological process of RFT1. This annotation is supported by phylogenetic inference and is consistent with direct biochemical evidence from Chen et al. 2024, which demonstrated that purified Rft1 catalyzes M5GN2-PP-Dol translocation across lipid bilayers.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Glycolipid translocation is the primary biological process function of RFT1. The 2024 reconstitution studies with purified protein definitively established this as the direct enzymatic function, resolving prior controversy about whether RFT1 directly catalyzes translocation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/38886340" target="_blank" class="term-link">
                                        PMID:38886340
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">describe a completely reconstituted in vitro assay for M5GN2-PP-Dol translocation and demonstrate that purified Rft1 catalyzes the translocation of M5GN2-PP-Dol across the lipid bilayer.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/RFT1/RFT1-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">Purified human RFT1 directly catalyzes the transbilayer movement of M5GN2-PP-Dol</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005789" target="_blank" class="term-link">
                                    GO:0005789
                                </a>
                            </span>
                            <span class="term-label">endoplasmic reticulum membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000044
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q96AA3" data-a="GO:0005789" data-r="GO_REF:0000044" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping. This is consistent with the more specific IBA annotation and direct experimental evidence from PMID:18313027.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While this is a computational annotation, it correctly reflects the established ER membrane localization of RFT1 and is consistent with experimental evidence.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/18313027" target="_blank" class="term-link">
                                        PMID:18313027
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">RFT1 deficiency in both yeast and human cells leads to the accumulation of incomplete DolPP-GlcNAc(2)Man(5) and to a profound glycosylation disorder in humans.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006488" target="_blank" class="term-link">
                                    GO:0006488
                                </a>
                            </span>
                            <span class="term-label">dolichol-linked oligosaccharide biosynthetic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q96AA3" data-a="GO:0006488" data-r="GO_REF:0000002" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA annotation based on InterPro domain mapping (IPR007594). RFT1 participates in dolichol-linked oligosaccharide biosynthesis by translocating the M5GN2-PP-Dol intermediate to enable lumenal elongation to the mature Glc3Man9GlcNAc2-PP-Dol precursor.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This process annotation is accurate. RFT1 functions in LLO biosynthesis by catalyzing the essential translocation step that allows completion of the oligosaccharide assembly in the ER lumen. Without RFT1 function, LLO biosynthesis is blocked at the M5GN2 stage.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/18313027" target="_blank" class="term-link">
                                        PMID:18313027
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">N-linked glycosylation is an essential posttranslational modification of proteins in eukaryotes. The substrate of N-linked glycosylation, dolichol pyrophosphate (DolPP)-GlcNAc(2)Man(9)Glc(3), is assembled through a complex series of ordered reactions requiring the translocation of the intermediate DolPP-GlcNAc(2)Man(5) structure across the endoplasmic-reticulum membrane.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/38886340" target="_blank" class="term-link">
                                        PMID:38886340
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">studies identified Rft1 as the M5GN2-PP-Dol flippase in vivo but are at odds with biochemical data suggesting Rft1 is dispensable for flipping in vitro.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016020" target="_blank" class="term-link">
                                    GO:0016020
                                </a>
                            </span>
                            <span class="term-label">membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q96AA3" data-a="GO:0016020" data-r="GO_REF:0000002" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA annotation for general membrane localization based on InterPro domain mapping. This is accurate but less specific than the ER membrane annotations.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While technically correct (RFT1 is a membrane protein), this annotation is overly general. The more specific GO:0005789 (endoplasmic reticulum membrane) annotations better capture the actual localization. Retained as it does not conflict with more specific annotations.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/RFT1/RFT1-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">Human RFT1 localizes throughout the ER. DeepTMHMM and experimental tagging/topology mapping indicate ~14 transmembrane spans</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/32296183" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:32296183
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    A reference map of the human binary protein interactome.
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="Q96AA3" data-a="GO:0005515" data-r="PMID:32296183" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IPI annotation from the HuRI (Human Reference Interactome) high-throughput yeast two-hybrid screen. RFT1 was found to interact with multiple proteins in this systematic binary protein interactome mapping study.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The generic &#34;protein binding&#34; term is uninformative for GO annotation purposes, as it does not specify the functional consequence of these interactions. Furthermore, these high-throughput Y2H interactions lack validation for functional relevance to RFT1&#39;s core flippase activity. None of these interactors have established roles in the N-glycosylation or LLO translocation pathway. Following GO curation guidelines, generic protein binding annotations should be avoided when more specific molecular function terms are available.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0034202" target="_blank" class="term-link">
                                    GO:0034202
                                </a>
                            </span>
                            <span class="term-label">glycolipid floppase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/38886340" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:38886340
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Rft1 catalyzes lipid-linked oligosaccharide translocation ac...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q96AA3" data-a="GO:0034202" data-r="PMID:38886340" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IDA annotation for glycolipid floppase activity based on the landmark 2024 Chen et al. study that demonstrated direct flippase activity using purified protein in reconstituted proteoliposomes. The study showed that purified Rft1 catalyzes the translocation of M5GN2-PP-Dol/Phy across lipid bilayers with high efficiency (~90% conversion to mannosidase-accessible product within 2 hours) and substrate selectivity for M5 over M3 intermediates.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is the definitive molecular function annotation for RFT1. The 2024 reconstitution studies resolved the longstanding controversy about whether RFT1 directly catalyzes translocation or acts indirectly. Purified protein was shown to be necessary and sufficient for flippase activity, establishing this as the core molecular function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/38886340" target="_blank" class="term-link">
                                        PMID:38886340
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">describe a completely reconstituted in vitro assay for M5GN2-PP-Dol translocation and demonstrate that purified Rft1 catalyzes the translocation of M5GN2-PP-Dol across the lipid bilayer.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/38886340" target="_blank" class="term-link">
                                        PMID:38886340
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Rft1 is specific for M5GN2-PP-Dol translocation</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0034203" target="_blank" class="term-link">
                                    GO:0034203
                                </a>
                            </span>
                            <span class="term-label">glycolipid translocation</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/38886340" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:38886340
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Rft1 catalyzes lipid-linked oligosaccharide translocation ac...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q96AA3" data-a="GO:0034203" data-r="PMID:38886340" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IDA annotation for glycolipid translocation based on the same 2024 Chen et al. reconstitution study. This biological process annotation complements the molecular function annotation (GO:0034202) by capturing the process outcome of the flippase activity.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Glycolipid translocation is the core biological process function demonstrated experimentally. The IDA evidence from reconstituted proteoliposome assays provides definitive proof that RFT1 mediates this process.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/38886340" target="_blank" class="term-link">
                                        PMID:38886340
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Purified Rft1 and HhAgl23 translocate lipid-linked M5GN2 intermediate across the lipid bilayer</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/RFT1/RFT1-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">Direct flipping of M5GN2-PP-Dol/Phy by purified Rft1 in proteoliposomes with mannosidase-coupled UPLC-MS readout</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0034202" target="_blank" class="term-link">
                                    GO:0034202
                                </a>
                            </span>
                            <span class="term-label">glycolipid floppase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-4570573
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q96AA3" data-a="GO:0034202" data-r="Reactome:R-HSA-4570573" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> TAS annotation from Reactome pathway &#34;Defective RFT1 does not flip the N-glycan precursor&#34; (R-HSA-4570573). This annotation is based on traceable author statements in the literature supporting RFT1&#39;s role as a flippase in the N-glycosylation pathway.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This annotation is consistent with the established molecular function of RFT1 and is supported by both genetic (PMID:18313027) and biochemical (PMID:38886340) evidence. Reactome accurately captures this pathway role.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/18313027" target="_blank" class="term-link">
                                        PMID:18313027
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The human RFT1 protein shares 22% identity with its yeast ortholog, which is involved in the translocation of DolPP-GlcNAc(2)Man(5) from the cytosolic into the lumenal side of the endoplasmic reticulum.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005789" target="_blank" class="term-link">
                                    GO:0005789
                                </a>
                            </span>
                            <span class="term-label">endoplasmic reticulum membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IGI</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/18313027" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:18313027
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Human RFT1 deficiency leads to a disorder of N-linked glycos...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q96AA3" data-a="GO:0005789" data-r="PMID:18313027" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IGI annotation based on genetic interaction evidence from the 2008 Haeuptle et al. study. Human RFT1 was shown to complement yeast delta-rft1 cells, demonstrating functional orthology and implying shared ER membrane localization.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The genetic complementation evidence strongly supports ER membrane localization, as the human protein functions in the same cellular compartment and pathway as the yeast ortholog.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/18313027" target="_blank" class="term-link">
                                        PMID:18313027
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Despite the low sequence similarity between the yeast and the human RFT1 proteins, we demonstrated both their functional orthology and the pathologic effect of the human p.R67C mutation by complementation assay in Deltarft1 yeast cells.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006487" target="_blank" class="term-link">
                                    GO:0006487
                                </a>
                            </span>
                            <span class="term-label">protein N-linked glycosylation</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/18313027" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:18313027
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Human RFT1 deficiency leads to a disorder of N-linked glycos...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q96AA3" data-a="GO:0006487" data-r="PMID:18313027" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IMP annotation for protein N-linked glycosylation based on mutant phenotype analysis in RFT1-CDG patient cells. Loss of RFT1 function leads to hypoglycosylation of proteins, demonstrating its essential role in the N-glycosylation pathway.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is a well-supported core function annotation. RFT1 is essential for N-glycosylation because it translocates the LLO intermediate required for lumenal completion of the glycan precursor. Patient cells show accumulation of M5GN2-PP-Dol and hypoglycosylation of proteins.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/18313027" target="_blank" class="term-link">
                                        PMID:18313027
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">A young patient diagnosed with a congenital disorder of glycosylation characterized by an intracellular accumulation of DolPP-GlcNAc(2)Man(5) was found to carry a homozygous point mutation in the RFT1 gene.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/18313027" target="_blank" class="term-link">
                                        PMID:18313027
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The causality of the RFT1 p.R67C mutation was further established by restoration of normal glycosylation profiles in patient-derived fibroblasts after lentiviral expression of a normal RFT1 cDNA.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006488" target="_blank" class="term-link">
                                    GO:0006488
                                </a>
                            </span>
                            <span class="term-label">dolichol-linked oligosaccharide biosynthetic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/18313027" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:18313027
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Human RFT1 deficiency leads to a disorder of N-linked glycos...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q96AA3" data-a="GO:0006488" data-r="PMID:18313027" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IMP annotation for dolichol-linked oligosaccharide biosynthetic process based on mutant phenotype analysis. RFT1-deficient cells accumulate M5GN2-PP-Dol and fail to produce the mature LLO precursor, demonstrating the essential role of RFT1 in this biosynthetic pathway.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> RFT1 is directly involved in LLO biosynthesis by enabling translocation of the intermediate to the ER lumen for completion. This is a core process annotation with strong IMP evidence.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/18313027" target="_blank" class="term-link">
                                        PMID:18313027
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">RFT1 deficiency in both yeast and human cells leads to the accumulation of incomplete DolPP-GlcNAc(2)Man(5) and to a profound glycosylation disorder in humans.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0034203" target="_blank" class="term-link">
                                    GO:0034203
                                </a>
                            </span>
                            <span class="term-label">glycolipid translocation</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IGI</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/18313027" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:18313027
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Human RFT1 deficiency leads to a disorder of N-linked glycos...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q96AA3" data-a="GO:0034203" data-r="PMID:18313027" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IGI annotation for glycolipid translocation based on genetic interaction evidence from yeast complementation studies. Human RFT1 complements yeast Rft1 function in glycolipid translocation.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This annotation captures the core biological process function of RFT1 based on genetic interaction evidence. The complementation studies demonstrate functional conservation of the translocation activity.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/18313027" target="_blank" class="term-link">
                                        PMID:18313027
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The definition of the RFT1 defect establishes the functional conservation of the DolPP-GlcNAc(2)Man(5) translocation process in eukaryotes.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005789" target="_blank" class="term-link">
                                    GO:0005789
                                </a>
                            </span>
                            <span class="term-label">endoplasmic reticulum membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-4570573
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q96AA3" data-a="GO:0005789" data-r="Reactome:R-HSA-4570573" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> TAS annotation from Reactome for ER membrane localization. This is consistent with the established localization from multiple experimental sources and computational predictions.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> ER membrane localization is well-established and this TAS annotation is consistent with experimental evidence. RFT1 functions as an integral ER membrane protein in the N-glycosylation pathway.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/18313027" target="_blank" class="term-link">
                                        PMID:18313027
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The human RFT1 protein shares 22% identity with its yeast ortholog, which is involved in the translocation of DolPP-GlcNAc(2)Man(5) from the cytosolic into the lumenal side of the endoplasmic reticulum.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
            </tbody>
        </table>
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Core Functions</h2>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>Glycolipid floppase activity - catalyzes translocation of Man5GlcNAc2-PP-dolichol from cytosolic to lumenal leaflet of the ER membrane, enabling completion of LLO biosynthesis for N-glycosylation.</h3>
                <span class="vote-buttons" data-g="Q96AA3" data-a="FUNCTION: Glycolipid floppase activity - catalyzes transloca..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0034202" target="_blank" class="term-link">
                            glycolipid floppase activity
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0034203" target="_blank" class="term-link">
                                glycolipid translocation
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006488" target="_blank" class="term-link">
                                dolichol-linked oligosaccharide biosynthetic process
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006487" target="_blank" class="term-link">
                                protein N-linked glycosylation
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005789" target="_blank" class="term-link">
                                endoplasmic reticulum membrane
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                
            </div>

            
            <div style="margin-top: 1rem; padding-top: 1rem; border-top: 1px solid var(--border-color);">
                <strong>Supporting Evidence:</strong>
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/38886340" target="_blank" class="term-link">
                                PMID:38886340
                            </a>
                            
                        </span>
                        
                        <div class="finding-text">describe a completely reconstituted in vitro assay for M5GN2-PP-Dol translocation and demonstrate that purified Rft1 catalyzes the translocation of M5GN2-PP-Dol across the lipid bilayer.</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/18313027" target="_blank" class="term-link">
                                PMID:18313027
                            </a>
                            
                        </span>
                        
                        <div class="finding-text">The human RFT1 protein shares 22% identity with its yeast ortholog, which is involved in the translocation of DolPP-GlcNAc(2)Man(5) from the cytosolic into the lumenal side of the endoplasmic reticulum.</div>
                        
                    </li>
                    
                </ul>
            </div>
            
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title collapsible">References</h2>
        <div class="collapse-content">
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000002.md" target="_blank" class="term-link">
                            GO_REF:0000002
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation through association of InterPro records with GO terms</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">InterPro domain IPR007594 (RFT1) infers membrane localization and role in LLO biosynthesis</div>
                        
                        <div class="finding-text">"Gene Ontology annotation through association of InterPro records with GO terms"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000033.md" target="_blank" class="term-link">
                            GO_REF:0000033
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Annotation inferences using phylogenetic trees</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">IBA annotations for ER membrane localization and glycolipid translocation based on PANTHER</div>
                        
                        <div class="finding-text">"Annotation inferences using phylogenetic trees"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000044.md" target="_blank" class="term-link">
                            GO_REF:0000044
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">IEA annotation for ER membrane based on UniProt subcellular location data</div>
                        
                        <div class="finding-text">"Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/18313027" target="_blank" class="term-link">
                            PMID:18313027
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Human RFT1 deficiency leads to a disorder of N-linked glycosylation.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Identified RFT1 mutations as cause of CDG type 1N</div>
                        
                        <div class="finding-text">"A young patient diagnosed with a congenital disorder of glycosylation characterized by an intracellular accumulation of DolPP-GlcNAc(2)Man(5) was found to carry a homozygous point mutation in the RFT1 gene."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Demonstrated functional orthology between human and yeast RFT1 via complementation</div>
                        
                        <div class="finding-text">"Despite the low sequence similarity between the yeast and the human RFT1 proteins, we demonstrated both their functional orthology and the pathologic effect of the human p.R67C mutation by complementation assay in Deltarft1 yeast cells."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Patient cells accumulate M5GN2-PP-Dol intermediate due to RFT1 deficiency</div>
                        
                        <div class="finding-text">"RFT1 deficiency in both yeast and human cells leads to the accumulation of incomplete DolPP-GlcNAc(2)Man(5) and to a profound glycosylation disorder in humans."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Causality established by rescue of patient fibroblasts with wild-type RFT1</div>
                        
                        <div class="finding-text">"The causality of the RFT1 p.R67C mutation was further established by restoration of normal glycosylation profiles in patient-derived fibroblasts after lentiviral expression of a normal RFT1 cDNA."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">RFT1 mediates translocation of M5GN2-PP-Dol to ER lumen</div>
                        
                        <div class="finding-text">"The human RFT1 protein shares 22% identity with its yeast ortholog, which is involved in the translocation of DolPP-GlcNAc(2)Man(5) from the cytosolic into the lumenal side of the endoplasmic reticulum."</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/32296183" target="_blank" class="term-link">
                            PMID:32296183
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">A reference map of the human binary protein interactome.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">High-throughput Y2H study (HuRI) identifying RFT1 protein-protein interactions</div>
                        
                        <div class="finding-text">"Here we present a human &#39;all-by-all&#39; reference interactome map of human binary protein interactions, or &#39;HuRI&#39;."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Interactions detected with various proteins but functional relevance to RFT1 core function not established</div>
                        
                        <div class="finding-text">"Global insights into cellular organization and genome function require comprehensive understanding of the interactome networks"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/38886340" target="_blank" class="term-link">
                            PMID:38886340
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Purified Rft1 directly catalyzes M5GN2-PP-Dol translocation across membranes</div>
                        
                        <div class="finding-text">"describe a completely reconstituted in vitro assay for M5GN2-PP-Dol translocation and demonstrate that purified Rft1 catalyzes the translocation of M5GN2-PP-Dol across the lipid bilayer."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Demonstrated substrate selectivity for M5 over M3 intermediates</div>
                        
                        <div class="finding-text">"Rft1 is specific for M5GN2-PP-Dol translocation"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Evolutionary conservation with archaeal ortholog HhAgl23</div>
                        
                        <div class="finding-text">"Purified Rft1 and HhAgl23 translocate lipid-linked M5GN2 intermediate across the lipid bilayer"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-4570573
                        
                    </span>
                </div>
                
                <div class="reference-title">Defective RFT1 does not flip the N-glycan precursor</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        file:human/RFT1/RFT1-deep-research-falcon.md
                        
                    </span>
                </div>
                
                <div class="reference-title">Deep research on RFT1 function (2024)</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">ER localization and topology of human RFT1</div>
                        
                        <div class="finding-text">"Human RFT1 localizes throughout the ER. DeepTMHMM and experimental tagging/topology mapping indicate ~14 transmembrane spans with both N- and C-termini facing the cytosol"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">2024 biochemical evidence for direct flippase activity</div>
                        
                        <div class="finding-text">"Purified human RFT1 directly catalyzes the transbilayer movement of M5GN2-PP-Dol"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
        </div>
    </div>
    


    

    

    

    <!-- Additional Documentation Sections -->
    
    <div class="section">
        <h2 class="section-title">üìö Additional Documentation</h2>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Falcon</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(RFT1-deep-research-falcon.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q96AA3" data-a="DOC: Deep Research Falcon" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: falcon<br />
model: Edison Scientific Literature<br />
cached: false<br />
start_time: '2025-12-26T23:20:50.387302'<br />
end_time: '2025-12-26T23:35:44.898146'<br />
duration_seconds: 894.51<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: RFT1<br />
  gene_symbol: RFT1<br />
  uniprot_accession: Q96AA3<br />
  protein_description: 'RecName: Full=Man(5)GlcNAc(2)-PP-dolichol translocation protein<br />
    RFT1 {ECO:0000305|PubMed:18313027}; AltName: Full=Protein RFT1 homolog {ECO:0000312|HGNC:HGNC:30220};'<br />
  gene_info: Name=RFT1 {ECO:0000312|HGNC:HGNC:30220};<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Belongs to the RFT1 family. .<br />
  protein_domains: RFT1. (IPR007594); Rft-1 (PF04506)<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    temperature: 0.1<br />
citation_count: 18</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q96AA3</li>
<li><strong>Protein Description:</strong> RecName: Full=Man(5)GlcNAc(2)-PP-dolichol translocation protein RFT1 {ECO:0000305|PubMed:18313027}; AltName: Full=Protein RFT1 homolog {ECO:0000312|HGNC:HGNC:30220};</li>
<li><strong>Gene Information:</strong> Name=RFT1 {ECO:0000312|HGNC:HGNC:30220};</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Belongs to the RFT1 family. .</li>
<li><strong>Key Domains:</strong> RFT1. (IPR007594); Rft-1 (PF04506)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "RFT1" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'RFT1' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>RFT1</strong> (gene ID: RFT1, UniProt: Q96AA3) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<p>Question: You are an expert researcher providing comprehensive, well-cited information.</p>
<p>Provide detailed information focusing on:<br />
1. Key concepts and definitions with current understanding<br />
2. Recent developments and latest research (prioritize 2023-2024 sources)<br />
3. Current applications and real-world implementations<br />
4. Expert opinions and analysis from authoritative sources<br />
5. Relevant statistics and data from recent studies</p>
<p>Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.<br />
Always prioritize recent, authoritative sources and provide specific citations for all major claims.</p>
<h1 id="gene-research-for-functional-annotation_1">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context_1">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot_1">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q96AA3</li>
<li><strong>Protein Description:</strong> RecName: Full=Man(5)GlcNAc(2)-PP-dolichol translocation protein RFT1 {ECO:0000305|PubMed:18313027}; AltName: Full=Protein RFT1 homolog {ECO:0000312|HGNC:HGNC:30220};</li>
<li><strong>Gene Information:</strong> Name=RFT1 {ECO:0000312|HGNC:HGNC:30220};</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Belongs to the RFT1 family. .</li>
<li><strong>Key Domains:</strong> RFT1. (IPR007594); Rft-1 (PF04506)</li>
</ul>
<h3 id="mandatory-verification-steps_1">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "RFT1" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature_1">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'RFT1' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target_1">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>RFT1</strong> (gene ID: RFT1, UniProt: Q96AA3) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<p>Plan<br />
Objective 1. Verify identity and resolve ambiguities. Completed by cross-referencing 2024 mechanistic and molecular characterizations that explicitly study human RFT1 and its yeast/human orthology relationships, confirming the human ER protein RFT1 with polytopic topology, and by aligning mechanistic role and domains with RFT1/MOP family features (see Evidence). (hirata2024molecularcharacterizationof pages 1-3, hirata2024molecularcharacterizationof pages 8-10)<br />
Objective 2‚Äì5. Curate primary literature, recent developments, disease relevance, and expert analysis; emphasize 2023‚Äì2024 sources. Achieved via 2024 Nature Communications (direct reconstitution) and 2024 molecular characterization, complemented by clinical/diagnostic primary literature and systematic reviews. (chen2024rft1catalyzeslipidlinked pages 2-3, chen2024rft1catalyzeslipidlinked pages 4-4, chen2024rft1catalyzeslipidlinked pages 5-6, hirata2024molecularcharacterizationof pages 1-3, vleugels2009rft1deficiencyin pages 1-3, colantuono2021liverinvolvementin pages 6-8, vleugels2009rft1deficiencyin pages 3-4)<br />
Objective 6. Create a concise artifact table summarizing key facts. See embedded artifact.<br />
Objective 7. Synthesize the full research report with citations and URLs. Submitted below.</p>
<table>
<thead>
<tr>
<th>Aspect</th>
<th>Key details</th>
<th>Primary sources (year, DOI/URL)</th>
</tr>
</thead>
<tbody>
<tr>
<td>Identity (gene/protein, organism, family/domain)</td>
<td>Human RFT1 (UniProt Q96AA3), member of the RFT1/MOP transporter family; polytopic membrane protein implicated in LLO translocation.</td>
<td>2024, Chen et al., DOI: https://doi.org/10.1038/s41467-024-48999-3 (chen2024rft1catalyzeslipidlinked pages 2-3); 2024, Hirata et al., DOI: https://doi.org/10.1101/2024.04.03.587922 (hirata2024molecularcharacterizationof pages 1-3)</td>
</tr>
<tr>
<td>Subcellular localization &amp; topology</td>
<td>Endoplasmic reticulum (ER) resident; predicted ~14 transmembrane spans with both N- and C-termini cytosolic; not N-glycosylated.</td>
<td>2024, Hirata et al., DOI: https://doi.org/10.1101/2024.04.03.587922 (hirata2024molecularcharacterizationof pages 8-10, hirata2024molecularcharacterizationof pages 22-26)</td>
</tr>
<tr>
<td>Primary molecular function &amp; substrate specificity</td>
<td>Catalyzes translocation (flipping) of Man5GlcNAc2-PP-dolichol (M5GN2-PP-Dol/Phy) across the ER membrane; shows selectivity for M5 over M3 intermediates.</td>
<td>2024, Chen et al., DOI: https://doi.org/10.1038/s41467-024-48999-3 (chen2024rft1catalyzeslipidlinked pages 2-3, chen2024rft1catalyzeslipidlinked pages 4-4, chen2024rft1catalyzeslipidlinked pages 5-6); mechanistic/topology context (hirata2024molecularcharacterizationof pages 1-3)</td>
</tr>
<tr>
<td>Pathway role (N-glycosylation step/mechanism)</td>
<td>Performs the cytosolic-to-lumenal translocation of the heptasaccharide intermediate (M5GN2-PP-Dol), enabling lumenal extension to Glc3Man9GlcNAc2-PP-Dol and subsequent OST-mediated transfer to nascent proteins.</td>
<td>2024, Chen et al., DOI: https://doi.org/10.1038/s41467-024-48999-3 (chen2024rft1catalyzeslipidlinked pages 2-3); pathway context and reviews (hirata2024molecularcharacterizationof pages 1-3)</td>
</tr>
<tr>
<td>2023‚Äì2024 developments resolving flippase controversy</td>
<td>2024 reconstitution with purified Rft1 (and archaeal orthologue) demonstrated direct M5GN2-PP flipping (Nature Communications), while parallel 2024 molecular work characterized Rft1 topology and noted prior reconstitution assays where removal of Rft1 did not abolish bulk scramblase activity ‚Äî together they provide direct biochemical proof of activity yet explain earlier discrepant results (differences in assay systems, abundance, suppressor bypass).</td>
<td>2024, Chen et al., DOI: https://doi.org/10.1038/s41467-024-48999-3 (chen2024rft1catalyzeslipidlinked pages 2-3); 2024, Hirata et al., DOI: https://doi.org/10.1101/2024.04.03.587922 (hirata2024molecularcharacterizationof pages 3-5, hirata2024molecularcharacterizationof pages 7-8, hirata2024molecularcharacterizationof pages 22-26)</td>
</tr>
<tr>
<td>Experimental evidence types</td>
<td>Genetic complementation (yeast/plasmid-shuffle), patient fibroblast complementation, biochemical reconstitution in proteoliposomes with purified protein and UPLC-MS mannosidase readout, LLO profiling/HPLC, structural modeling (AlphaFold2), yeast functional assays (CPY glycosylation).</td>
<td>2024, Chen et al., DOI: https://doi.org/10.1038/s41467-024-48999-3 (chen2024rft1catalyzeslipidlinked pages 2-3); 2024, Hirata et al., DOI: https://doi.org/10.1101/2024.04.03.587922; 2009, Vleugels et al., DOI: https://doi.org/10.1002/humu.21085 (vleugels2009rft1deficiencyin pages 1-3)</td>
</tr>
<tr>
<td>Disease association (RFT1-CDG) &amp; hallmark phenotypes</td>
<td>Autosomal recessive RFT1-CDG (OMIM 612015): early-onset multisystem CDG dominated by severe neurodevelopmental disease (intractable epilepsy/epileptic encephalopathy, developmental delay, hypotonia), sensorineural deafness, feeding/respiratory problems, variable hepatic involvement.</td>
<td>2009, Vleugels et al., DOI: https://doi.org/10.1002/humu.21085 (vleugels2009rft1deficiencyin pages 1-3); 2021, Colantuono et al., DOI: https://doi.org/10.1097/mpg.0000000000003209 (colantuono2021liverinvolvementin pages 6-8); 2024 review/compilation (hirata2024molecularcharacterizationof pages 40-41)</td>
</tr>
<tr>
<td>Diagnostics (transferrin IEF, LLO profiling, functional rescue)</td>
<td>Typical diagnostic findings: type I transferrin (serum) pattern; LLO profiling/HPLC or radiolabel shows accumulation of Man5GlcNAc2-PP-dolichol; functional rescue of patient fibroblast defects by expression of WT RFT1 (restores LLO profile and glycoprotein secretion).</td>
<td>2009, Vleugels et al., DOI: https://doi.org/10.1002/humu.21085 (vleugels2009rft1deficiencyin pages 3-4, vleugels2009rft1deficiencyin pages 11-13, vleugels2009rft1deficiencyin pages 1-3)</td>
</tr>
<tr>
<td>Epidemiology / reported cases</td>
<td>Rare: initial series described 3 novel patients (2009) plus earlier index cases; later reviews note ~9 patients reported in some compilations ‚Äî overall case count remains small and heterogeneous across reports.</td>
<td>2009, Vleugels et al., DOI: https://doi.org/10.1002/humu.21085 (vleugels2009rft1deficiencyin pages 1-3); 2021, Colantuono et al. systematic review (colantuono2021liverinvolvementin pages 6-8); 2024 molecular review (hirata2024molecularcharacterizationof pages 40-41)</td>
</tr>
<tr>
<td>Applications / implications (diagnostics, biotechnology)</td>
<td>Clinical: inclusion in CDG diagnostic panels, transferrin/LLO testing, genotype-based counseling; Research/biotech: mechanistic model for flippase/MOP family transporters, target for glycoengineering studies and understanding LLO biogenesis; purified Rft1 enables mechanistic assays and potential screening.</td>
<td>2024, Chen et al., DOI: https://doi.org/10.1038/s41467-024-48999-3 (chen2024rft1catalyzeslipidlinked pages 2-3); 2024, Hirata et al., DOI: https://doi.org/10.1101/2024.04.03.587922 (hirata2024molecularcharacterizationof pages 1-3)</td>
</tr>
</tbody>
</table>
<p><em>Table: Concise, cited summary of key properties, function, evidence, disease links, diagnostics, and recent 2024 advances for human RFT1 (UniProt Q96AA3). This table compiles experimental and clinical sources to support functional annotation and translational relevance.</em></p>
<p>Comprehensive research report: Human RFT1 (UniProt Q96AA3)</p>
<p>1) Key concepts and definitions<br />
‚Ä¢ Identity and family: RFT1 (HGNC:30220) encodes a multi-pass ER membrane protein required for lipid-linked oligosaccharide (LLO) biogenesis in the N-glycosylation pathway. Recent structural homology and AlphaFold2 modeling place human RFT1 within the broader MOP (multidrug/oligosaccharidyl-lipid/polysaccharide) transporter superfamily that includes bacterial lipid II flippase MurJ, consistent with a transporter/scaffold for a large amphipathic lipid-linked glycan substrate (predicted ~14 TMs, cytosolic N- and C-termini). (Hirata et al., 2024; URL: https://doi.org/10.1101/2024.04.03.587922) (hirata2024molecularcharacterizationof pages 7-8, hirata2024molecularcharacterizationof pages 8-10)<br />
‚Ä¢ Primary substrate: the N-glycosylation intermediate Man5GlcNAc2-PP-dolichol (abbreviated M5GN2-PP-Dol or M5-DLO), which must move from the cytosolic to the luminal leaflet of the ER membrane to complete LLO assembly. (Chen et al., 2024; URL: https://doi.org/10.1038/s41467-024-48999-3) (chen2024rft1catalyzeslipidlinked pages 2-3)<br />
‚Ä¢ Pathway context: Synthesis of Glc3Man9GlcNAc2-PP-dolichol proceeds in two stages; the cytosolic heptasaccharide intermediate M5GN2-PP-Dol is flipped to the ER lumen where elongation yields Glc3Man9GlcNAc2-PP-Dol for transfer to nascent polypeptides by the OST complex. (Chen et al., 2024; URL: https://doi.org/10.1038/s41467-024-48999-3) (chen2024rft1catalyzeslipidlinked pages 2-3)</p>
<p>2) Molecular function, mechanism, localization, and topology<br />
‚Ä¢ Subcellular localization and topology: Human RFT1 localizes throughout the ER. DeepTMHMM and experimental tagging/topology mapping indicate ~14 transmembrane spans with both N- and C-termini facing the cytosol; the single canonical N-glycosylation sequon lies in an intracellular loop, and the protein is not N-glycosylated. (Hirata et al., 2024; URL: https://doi.org/10.1101/2024.04.03.587922) (hirata2024molecularcharacterizationof pages 7-8, hirata2024molecularcharacterizationof pages 22-26, hirata2024molecularcharacterizationof pages 8-10)<br />
‚Ä¢ Primary function and specificity: Purified human RFT1 directly catalyzes the transbilayer movement of M5GN2-PP-Dol (and the analogous phytanyl carrier substrate), with strong selectivity for M5 over shorter M3 intermediates in a fully reconstituted proteoliposome assay using an Œ±-mannosidase/UPLC-MS readout. (Chen et al., 2024; URL: https://doi.org/10.1038/s41467-024-48999-3) (chen2024rft1catalyzeslipidlinked pages 4-4, chen2024rft1catalyzeslipidlinked pages 5-6)<br />
‚Ä¢ Mechanistic notes: Structural modeling predicts an inward-open, alternating-access‚Äìlike transporter cavity containing conserved charged residues (e.g., R37, R63, R290, R442, E260) where many RFT1-CDG mutations map, consistent with a substrate-binding/translocation role for a large pyrophosphoryl-oligosaccharide lipid. (Hirata et al., 2024; URL: https://doi.org/10.1101/2024.04.03.587922) (hirata2024molecularcharacterizationof pages 8-10)</p>
<p>3) Recent developments and latest research (2023‚Äì2024)<br />
‚Ä¢ Definitive biochemical reconstitution: A major 2024 development resolved the long-standing controversy by demonstrating that purified Rft1 (yeast and human) is sufficient to catalyze M5GN2-PP-Dol translocation across membranes. Archaeal Agl23 also flips the same substrate, showing evolutionary conservation. These assays achieved ~90% conversion of M5GN2 to a diagnostic M3GN2 product accessible to exogenous mannosidase within 2 hours, while control liposomes or membrane fractions from an rft1Œî suppressor strain lacked activity. (Chen et al., 2024; URL: https://doi.org/10.1038/s41467-024-48999-3) (chen2024rft1catalyzeslipidlinked pages 4-4, chen2024rft1catalyzeslipidlinked pages 5-6)<br />
‚Ä¢ Molecular/structural characterization: Parallel 2024 work defined human RFT1 ER topology, quantified expression and glycosylation effects in yeast complementation, mapped conserved residues required for viability and N-glycosylation, and placed RFT1 in the MOP transporter superfamily. The same study reconciled prior biochemical observations where bulk M5-DLO scrambling persisted after Rft1 depletion by noting abundance differences and potential bypass/suppressor mechanisms; they emphasized the need for purified protein reconstitution (delivered by Chen et al. 2024). (Hirata et al., 2024; URL: https://doi.org/10.1101/2024.04.03.587922) (hirata2024molecularcharacterizationof pages 7-8, hirata2024molecularcharacterizationof pages 22-26, hirata2024molecularcharacterizationof pages 3-5)</p>
<p>4) Experimental evidence base<br />
‚Ä¢ Genetic complementation: Human RFT1 functionally replaces yeast Rft1 in viability and glycosylation assays; disease-residue variants define critical positions for function and growth. (Hirata et al., 2024; URL: https://doi.org/10.1101/2024.04.03.587922) (hirata2024molecularcharacterizationof pages 8-10)<br />
‚Ä¢ Biochemical reconstitution (purified protein): Direct flipping of M5GN2-PP-Dol/Phy by purified Rft1 in proteoliposomes with mannosidase-coupled UPLC-MS readout; selectivity for M5 over M3. (Chen et al., 2024; URL: https://doi.org/10.1038/s41467-024-48999-3) (chen2024rft1catalyzeslipidlinked pages 4-4, chen2024rft1catalyzeslipidlinked pages 5-6)<br />
‚Ä¢ Patient-cell functional rescue and LLO profiling: In RFT1-CDG fibroblasts, wild-type RFT1 cDNA corrects accumulated M5GN2-PP-Dol and restores secretion of a glycoprotein reporter (DNase I), establishing causality. (Vleugels et al., 2009; URL: https://doi.org/10.1002/humu.21085) (vleugels2009rft1deficiencyin pages 1-3, vleugels2009rft1deficiencyin pages 11-13)</p>
<p>5) Role in the N-glycosylation pathway<br />
‚Ä¢ Step: RFT1 flips the cytosolic M5GN2-PP-Dol intermediate into the ER lumen for elongation to Glc3Man9GlcNAc2-PP-Dol and downstream OST-mediated transfer to nascent polypeptides. (Chen et al., 2024; URL: https://doi.org/10.1038/s41467-024-48999-3) (chen2024rft1catalyzeslipidlinked pages 2-3)<br />
‚Ä¢ Pathway consequences of deficiency: Patient cells accumulate M5GN2-PP-Dol in the LLO pool with paucity of fully assembled LLO, leading to hypoglycosylation of proteins. (Vleugels et al., 2009; URL: https://doi.org/10.1002/humu.21085) (vleugels2009rft1deficiencyin pages 1-3, vleugels2009rft1deficiencyin pages 3-4)</p>
<p>6) Disease associations, phenotypes, and statistics<br />
‚Ä¢ Disorder: RFT1-CDG (OMIM 612015), an autosomal recessive congenital disorder of N-linked glycosylation. (Vleugels et al., 2009; URL: https://doi.org/10.1002/humu.21085) (vleugels2009rft1deficiencyin pages 6-7)<br />
‚Ä¢ Clinical spectrum (representative): severe neurodevelopmental disease (global developmental delay, hypotonia), intractable epilepsy including epileptic encephalopathy in infancy, universal sensorineural deafness in early series, feeding difficulties with aspiration, respiratory complications, and variable organ involvement (e.g., hepatomegaly reported; some series noted normal liver function). (Vleugels et al., 2009; URL: https://doi.org/10.1002/humu.21085; Colantuono et al., 2021; URL: https://doi.org/10.1097/mpg.0000000000003209) (vleugels2009rft1deficiencyin pages 4-6, vleugels2009rft1deficiencyin pages 6-7, colantuono2021liverinvolvementin pages 6-8)<br />
‚Ä¢ Reported case counts: Early clinical/molecular reports documented four total patients (three novel plus the index case). A later systematic review referenced ‚Äúsome of the nine patients reported‚Äù with RFT1-CDG features, indicating a total reported cohort on the order of single digits to low double digits in the literature at that time; overall, RFT1-CDG remains rare with few documented cases. (Vleugels et al., 2009; URL: https://doi.org/10.1002/humu.21085; Colantuono et al., 2021; URL: https://doi.org/10.1097/mpg.0000000000003209) (vleugels2009rft1deficiencyin pages 1-3, colantuono2021liverinvolvementin pages 6-8)</p>
<p>7) Diagnostics and real-world implementations<br />
‚Ä¢ Screening and confirmation: A Type I transferrin isoelectric focusing (IEF) pattern is typical of CDG-I defects. In RFT1-CDG, LLO profiling by radiolabel/HPLC demonstrates accumulation of M5GN2-PP-Dol with little fully assembled LLO and absence of M5GN2 on protein-linked glycans. Functional rescue by WT RFT1 in patient fibroblasts restores LLO composition and improves glycoprotein secretion (DNase I), supporting pathogenicity. These approaches inform clinical and research diagnostics. (Vleugels et al., 2009; URL: https://doi.org/10.1002/humu.21085) (vleugels2009rft1deficiencyin pages 3-4, vleugels2009rft1deficiencyin pages 11-13, vleugels2009rft1deficiencyin pages 1-3)<br />
‚Ä¢ Organ involvement in practice: Reviews emphasize neurological dominance, with reported hepatomegaly in some cases; phenotypes are heterogeneous, underscoring the utility of combined biochemical and genomic testing in suspected CDG. (Colantuono et al., 2021; URL: https://doi.org/10.1097/mpg.0000000000003209) (colantuono2021liverinvolvementin pages 6-8)</p>
<p>8) Expert analyses and interpretation<br />
‚Ä¢ Resolution of the ‚ÄúRFT1 flippase‚Äù controversy: 2024 purified-protein reconstitution provides direct biochemical evidence that Rft1 catalyzes M5GN2-PP-Dol flipping across membranes, reconciling earlier results where Rft1 depletion did not abolish bulk flipping in microsomes (likely due to suppressor/bypass and protein abundance issues). Structural/topological mapping supports a transporter mechanism aligned with MOP family principles and locates CDG mutations to a central cavity, strengthening the direct-actor model. (Chen et al., 2024; URL: https://doi.org/10.1038/s41467-024-48999-3; Hirata et al., 2024; URL: https://doi.org/10.1101/2024.04.03.587922) (chen2024rft1catalyzeslipidlinked pages 4-4, chen2024rft1catalyzeslipidlinked pages 5-6, hirata2024molecularcharacterizationof pages 7-8, hirata2024molecularcharacterizationof pages 8-10, hirata2024molecularcharacterizationof pages 22-26)<br />
‚Ä¢ Pathophysiology: Failure to flip M5GN2-PP-Dol impairs LLO completion, reducing N-glycosylation efficiency. The hallmark biochemical lesion‚ÄîM5GN2-PP-Dol accumulation with paucity of mature LLO‚Äîcorrelates with hypoglycosylation-dependent clinical phenotypes in RFT1-CDG. (Vleugels et al., 2009; URL: https://doi.org/10.1002/humu.21085) (vleugels2009rft1deficiencyin pages 1-3, vleugels2009rft1deficiencyin pages 3-4)</p>
<p>9) Applications and implications<br />
‚Ä¢ Diagnostics: Incorporate RFT1 into gene panels for CDG; use transferrin IEF as an initial screen, followed by LLO profiling and functional complementation where feasible. (Vleugels et al., 2009; URL: https://doi.org/10.1002/humu.21085) (vleugels2009rft1deficiencyin pages 3-4, vleugels2009rft1deficiencyin pages 11-13)<br />
‚Ä¢ Biotechnology and basic science: The availability of purified active Rft1 enables mechanistic biochemistry on substrate recognition and transport, guiding design of reconstituted glycosylation systems and informing glycoengineering strategies that depend on LLO supply and quality. The evolutionary conservation (archaeal suppressor/ortholog activity) invites comparative studies of MOP transporters. (Chen et al., 2024; URL: https://doi.org/10.1038/s41467-024-48999-3) (chen2024rft1catalyzeslipidlinked pages 2-3, chen2024rft1catalyzeslipidlinked pages 5-6)</p>
<p>Mandatory verification summary<br />
‚Ä¢ Gene symbol/protein match: Studied protein is human RFT1, consistent with the UniProt Q96AA3 description and the literature (ER polytopic protein that mediates M5GN2-PP-Dol translocation). (Hirata et al., 2024; Chen et al., 2024) (hirata2024molecularcharacterizationof pages 1-3, chen2024rft1catalyzeslipidlinked pages 2-3)<br />
‚Ä¢ Organism: Homo sapiens; cross-species complementation confirms orthology with yeast Rft1; human RFT1 rescues yeast rft1 deficiency. (Hirata et al., 2024) (hirata2024molecularcharacterizationof pages 22-26)<br />
‚Ä¢ Family/domains: RFT1 shows predicted MOP superfamily features with a central hydrophilic cavity; many pathogenic variants map to conserved residues in this region. (Hirata et al., 2024) (hirata2024molecularcharacterizationof pages 8-10)<br />
‚Ä¢ Ambiguity check: No conflicting gene symbol usage impacting humans was identified in the curated sources; where earlier literature questioned direct flippase activity, 2024 purified-protein assays now support a direct catalytic role for RFT1. (Chen et al., 2024; Hirata et al., 2024) (chen2024rft1catalyzeslipidlinked pages 4-4, hirata2024molecularcharacterizationof pages 7-8)</p>
<p>References (URLs and dates)<br />
‚Ä¢ Chen S. et al. Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane. Nature Communications. 2024-06. URL: https://doi.org/10.1038/s41467-024-48999-3 (chen2024rft1catalyzeslipidlinked pages 2-3, chen2024rft1catalyzeslipidlinked pages 4-4, chen2024rft1catalyzeslipidlinked pages 5-6)<br />
‚Ä¢ Hirata E. et al. Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG. 2024-04 (preprint/revised for JBC). URL: https://doi.org/10.1101/2024.04.03.587922 (hirata2024molecularcharacterizationof pages 1-3, hirata2024molecularcharacterizationof pages 7-8, hirata2024molecularcharacterizationof pages 22-26, hirata2024molecularcharacterizationof pages 8-10, hirata2024molecularcharacterizationof pages 40-41)<br />
‚Ä¢ Vleugels W. et al. RFT1 deficiency in three novel CDG patients. Human Mutation. 2009-10. URL: https://doi.org/10.1002/humu.21085 (vleugels2009rft1deficiencyin pages 1-3, vleugels2009rft1deficiencyin pages 4-6, vleugels2009rft1deficiencyin pages 6-7, vleugels2009rft1deficiencyin pages 11-13, vleugels2009rft1deficiencyin pages 3-4)<br />
‚Ä¢ Colantuono R. et al. Liver involvement in congenital disorders of glycosylation: a systematic review. JPGN. 2021-06. URL: https://doi.org/10.1097/mpg.0000000000003209 (colantuono2021liverinvolvementin pages 6-8)</p>
<p>References</p>
<ol>
<li>
<p>(hirata2024molecularcharacterizationof pages 1-3): Eri Hirata, Ken-taro Sakata, Grace I. Dearden, Faria Noor, Indu Menon, George N. Chiduza, and Anant K. Menon. Molecular characterization of rft1, an er membrane protein associated with congenital disorder of glycosylation rft1-cdg. The Journal of Biological Chemistry, Apr 2024. URL: https://doi.org/10.1101/2024.04.03.587922, doi:10.1101/2024.04.03.587922. This article has 4 citations.</p>
</li>
<li>
<p>(hirata2024molecularcharacterizationof pages 8-10): Eri Hirata, Ken-taro Sakata, Grace I. Dearden, Faria Noor, Indu Menon, George N. Chiduza, and Anant K. Menon. Molecular characterization of rft1, an er membrane protein associated with congenital disorder of glycosylation rft1-cdg. The Journal of Biological Chemistry, Apr 2024. URL: https://doi.org/10.1101/2024.04.03.587922, doi:10.1101/2024.04.03.587922. This article has 4 citations.</p>
</li>
<li>
<p>(chen2024rft1catalyzeslipidlinked pages 2-3): Shuai Chen, Cai-Xia Pei, Si Xu, Hanjie Li, Yi-Shi liu, Yicheng Wang, Cheng Jin, Neta Dean, and Xiao-Dong Gao. Rft1 catalyzes lipid-linked oligosaccharide translocation across the er membrane. Nature Communications, Jun 2024. URL: https://doi.org/10.1038/s41467-024-48999-3, doi:10.1038/s41467-024-48999-3. This article has 15 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(chen2024rft1catalyzeslipidlinked pages 4-4): Shuai Chen, Cai-Xia Pei, Si Xu, Hanjie Li, Yi-Shi liu, Yicheng Wang, Cheng Jin, Neta Dean, and Xiao-Dong Gao. Rft1 catalyzes lipid-linked oligosaccharide translocation across the er membrane. Nature Communications, Jun 2024. URL: https://doi.org/10.1038/s41467-024-48999-3, doi:10.1038/s41467-024-48999-3. This article has 15 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(chen2024rft1catalyzeslipidlinked pages 5-6): Shuai Chen, Cai-Xia Pei, Si Xu, Hanjie Li, Yi-Shi liu, Yicheng Wang, Cheng Jin, Neta Dean, and Xiao-Dong Gao. Rft1 catalyzes lipid-linked oligosaccharide translocation across the er membrane. Nature Communications, Jun 2024. URL: https://doi.org/10.1038/s41467-024-48999-3, doi:10.1038/s41467-024-48999-3. This article has 15 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(vleugels2009rft1deficiencyin pages 1-3): Wendy Vleugels, Micha A. Haeuptle, Bobby G. Ng, Jean-Claude Michalski, Roberta Battini, Carlo Dionisi-Vici, Mark D. Ludman, Jaak Jaeken, Fran√ßois Foulquier, Hudson H. Freeze, Gert Matthijs, and Thierry Hennet. Rft1 deficiency in three novel cdg patients. Human Mutation, 30:1428-1434, Oct 2009. URL: https://doi.org/10.1002/humu.21085, doi:10.1002/humu.21085. This article has 44 citations and is from a domain leading peer-reviewed journal.</p>
</li>
<li>
<p>(colantuono2021liverinvolvementin pages 6-8): Rossella Colantuono, Elisa D‚ÄôAcunto, Daniela Melis, Pietro Vajro, Hudson H. Freeze, and Claudia Mandato. Liver involvement in congenital disorders of glycosylation: a systematic review. Journal of Pediatric Gastroenterology and Nutrition, 73:444-454, Jun 2021. URL: https://doi.org/10.1097/mpg.0000000000003209, doi:10.1097/mpg.0000000000003209. This article has 12 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(vleugels2009rft1deficiencyin pages 3-4): Wendy Vleugels, Micha A. Haeuptle, Bobby G. Ng, Jean-Claude Michalski, Roberta Battini, Carlo Dionisi-Vici, Mark D. Ludman, Jaak Jaeken, Fran√ßois Foulquier, Hudson H. Freeze, Gert Matthijs, and Thierry Hennet. Rft1 deficiency in three novel cdg patients. Human Mutation, 30:1428-1434, Oct 2009. URL: https://doi.org/10.1002/humu.21085, doi:10.1002/humu.21085. This article has 44 citations and is from a domain leading peer-reviewed journal.</p>
</li>
<li>
<p>(hirata2024molecularcharacterizationof pages 22-26): Eri Hirata, Ken-taro Sakata, Grace I. Dearden, Faria Noor, Indu Menon, George N. Chiduza, and Anant K. Menon. Molecular characterization of rft1, an er membrane protein associated with congenital disorder of glycosylation rft1-cdg. The Journal of Biological Chemistry, Apr 2024. URL: https://doi.org/10.1101/2024.04.03.587922, doi:10.1101/2024.04.03.587922. This article has 4 citations.</p>
</li>
<li>
<p>(hirata2024molecularcharacterizationof pages 3-5): Eri Hirata, Ken-taro Sakata, Grace I. Dearden, Faria Noor, Indu Menon, George N. Chiduza, and Anant K. Menon. Molecular characterization of rft1, an er membrane protein associated with congenital disorder of glycosylation rft1-cdg. The Journal of Biological Chemistry, Apr 2024. URL: https://doi.org/10.1101/2024.04.03.587922, doi:10.1101/2024.04.03.587922. This article has 4 citations.</p>
</li>
<li>
<p>(hirata2024molecularcharacterizationof pages 7-8): Eri Hirata, Ken-taro Sakata, Grace I. Dearden, Faria Noor, Indu Menon, George N. Chiduza, and Anant K. Menon. Molecular characterization of rft1, an er membrane protein associated with congenital disorder of glycosylation rft1-cdg. The Journal of Biological Chemistry, Apr 2024. URL: https://doi.org/10.1101/2024.04.03.587922, doi:10.1101/2024.04.03.587922. This article has 4 citations.</p>
</li>
<li>
<p>(hirata2024molecularcharacterizationof pages 40-41): Eri Hirata, Ken-taro Sakata, Grace I. Dearden, Faria Noor, Indu Menon, George N. Chiduza, and Anant K. Menon. Molecular characterization of rft1, an er membrane protein associated with congenital disorder of glycosylation rft1-cdg. The Journal of Biological Chemistry, Apr 2024. URL: https://doi.org/10.1101/2024.04.03.587922, doi:10.1101/2024.04.03.587922. This article has 4 citations.</p>
</li>
<li>
<p>(vleugels2009rft1deficiencyin pages 11-13): Wendy Vleugels, Micha A. Haeuptle, Bobby G. Ng, Jean-Claude Michalski, Roberta Battini, Carlo Dionisi-Vici, Mark D. Ludman, Jaak Jaeken, Fran√ßois Foulquier, Hudson H. Freeze, Gert Matthijs, and Thierry Hennet. Rft1 deficiency in three novel cdg patients. Human Mutation, 30:1428-1434, Oct 2009. URL: https://doi.org/10.1002/humu.21085, doi:10.1002/humu.21085. This article has 44 citations and is from a domain leading peer-reviewed journal.</p>
</li>
<li>
<p>(vleugels2009rft1deficiencyin pages 6-7): Wendy Vleugels, Micha A. Haeuptle, Bobby G. Ng, Jean-Claude Michalski, Roberta Battini, Carlo Dionisi-Vici, Mark D. Ludman, Jaak Jaeken, Fran√ßois Foulquier, Hudson H. Freeze, Gert Matthijs, and Thierry Hennet. Rft1 deficiency in three novel cdg patients. Human Mutation, 30:1428-1434, Oct 2009. URL: https://doi.org/10.1002/humu.21085, doi:10.1002/humu.21085. This article has 44 citations and is from a domain leading peer-reviewed journal.</p>
</li>
<li>
<p>(vleugels2009rft1deficiencyin pages 4-6): Wendy Vleugels, Micha A. Haeuptle, Bobby G. Ng, Jean-Claude Michalski, Roberta Battini, Carlo Dionisi-Vici, Mark D. Ludman, Jaak Jaeken, Fran√ßois Foulquier, Hudson H. Freeze, Gert Matthijs, and Thierry Hennet. Rft1 deficiency in three novel cdg patients. Human Mutation, 30:1428-1434, Oct 2009. URL: https://doi.org/10.1002/humu.21085, doi:10.1002/humu.21085. This article has 44 citations and is from a domain leading peer-reviewed journal.</p>
</li>
</ol>
<h2 id="citations">Citations</h2>
<ol>
<li>hirata2024molecularcharacterizationof pages 1-3</li>
<li>colantuono2021liverinvolvementin pages 6-8</li>
<li>hirata2024molecularcharacterizationof pages 40-41</li>
<li>hirata2024molecularcharacterizationof pages 8-10</li>
<li>hirata2024molecularcharacterizationof pages 22-26</li>
<li>hirata2024molecularcharacterizationof pages 3-5</li>
<li>hirata2024molecularcharacterizationof pages 7-8</li>
<li>https://doi.org/10.1038/s41467-024-48999-3</li>
<li>https://doi.org/10.1101/2024.04.03.587922</li>
<li>https://doi.org/10.1101/2024.04.03.587922;</li>
<li>https://doi.org/10.1002/humu.21085</li>
<li>https://doi.org/10.1097/mpg.0000000000003209</li>
<li>https://doi.org/10.1002/humu.21085;</li>
<li>https://doi.org/10.1038/s41467-024-48999-3;</li>
<li>https://doi.org/10.1101/2024.04.03.587922,</li>
<li>https://doi.org/10.1038/s41467-024-48999-3,</li>
<li>https://doi.org/10.1002/humu.21085,</li>
<li>https://doi.org/10.1097/mpg.0000000000003209,</li>
</ol>
            </div>
        </details>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Openai</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(RFT1-deep-research-openai.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q96AA3" data-a="DOC: Deep Research Openai" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: openai<br />
model: o3-deep-research-2025-06-26<br />
cached: false<br />
start_time: '2025-12-27T21:17:09.602895'<br />
end_time: '2025-12-27T21:44:16.998777'<br />
duration_seconds: 1627.4<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: RFT1<br />
  gene_symbol: RFT1<br />
  uniprot_accession: Q96AA3<br />
  protein_description: 'RecName: Full=Man(5)GlcNAc(2)-PP-dolichol translocation protein<br />
    RFT1 {ECO:0000305|PubMed:18313027}; AltName: Full=Protein RFT1 homolog {ECO:0000312|HGNC:HGNC:30220};'<br />
  gene_info: Name=RFT1 {ECO:0000312|HGNC:HGNC:30220};<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Belongs to the RFT1 family. .<br />
  protein_domains: RFT1. (IPR007594); Rft-1 (PF04506)<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    temperature: 0.1<br />
    top_p: 1.0<br />
citation_count: 125</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q96AA3</li>
<li><strong>Protein Description:</strong> RecName: Full=Man(5)GlcNAc(2)-PP-dolichol translocation protein RFT1 {ECO:0000305|PubMed:18313027}; AltName: Full=Protein RFT1 homolog {ECO:0000312|HGNC:HGNC:30220};</li>
<li><strong>Gene Information:</strong> Name=RFT1 {ECO:0000312|HGNC:HGNC:30220};</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Belongs to the RFT1 family. .</li>
<li><strong>Key Domains:</strong> RFT1. (IPR007594); Rft-1 (PF04506)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "RFT1" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'RFT1' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>RFT1</strong> (gene ID: RFT1, UniProt: Q96AA3) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<h1 id="rft1-key-flippase-in-n-linked-glycosylation-and-its-functional-annotation">RFT1: Key Flippase in N-Linked Glycosylation and Its Functional Annotation</h1>
<h2 id="background-n-linked-glycosylation-and-the-role-of-rft1">Background: N-Linked Glycosylation and the Role of RFT1</h2>
<p>N-linked glycosylation is a fundamental process in which a pre-assembled oligosaccharide is attached to specific asparagine residues of nascent proteins in the endoplasmic reticulum (ER) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=Asparagine%20%28N%29,P%2C%20GlcNAc%20and%20five%20Man">pmc.ncbi.nlm.nih.gov</a>). This oligosaccharide precursor ‚Äì a 14-sugar <em>Glc<sub>3</sub>Man<sub>9</sub>GlcNAc<sub>2</sub></em> structure in humans ‚Äì is built on a lipid carrier (dolichol pyrophosphate) via a stepwise pathway (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=Glc3Man9GlcNAc2%20,to%20the%20asparagine%20residue%20of">pmc.ncbi.nlm.nih.gov</a>). The first seven sugars (two <em>N</em>-acetylglucosamines and five mannoses) are assembled on the cytosolic face of the ER, forming the intermediate <em>Man<sub>5</sub>GlcNAc<sub>2</sub>-PP-dolichol</em> (also called M5-DLO or a ‚Äúheptasaccharide‚Äù lipid intermediate) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=topologically%20distinct,to%20the%20asparagine%20residue%20of">pmc.ncbi.nlm.nih.gov</a>). This intermediate must then be <em>flipped</em> or translocated across the ER membrane into the lumen, where the remaining seven sugars (four mannoses and three glucoses) are added to complete the precursor (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=topologically%20distinct,to%20the%20asparagine%20residue%20of">pmc.ncbi.nlm.nih.gov</a>). The protein <strong>RFT1</strong> ‚Äì identified in yeast around 2002 as ‚ÄúRequired for <em>Flipping</em> of <em>Man<sub>5</sub>GlcNAc<sub>2</em>-PP-dolichol‚Äù ‚Äì is the membrane transporter responsible for this translocation step (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=identified%20Rft1%20by%20yeast%20genetics,vitro%20flipping%20assay%20using%20proteoliposomes">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=topologically%20distinct,to%20the%20asparagine%20residue%20of">pmc.ncbi.nlm.nih.gov</a>). In other words, RFT1 functions as the ER <em>flippase</em> (or scramblase) that flips the lipid-linked oligosaccharide from the cytosolic leaflet to the luminal leaflet of the ER membrane, a step essential for N-glycan biosynthesis (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=translocation%20and%20demonstrate%20that%20purified,Dol%20ER%20flippase">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=topologically%20distinct,to%20the%20asparagine%20residue%20of">pmc.ncbi.nlm.nih.gov</a>). This role is critical: without RFT1, the oligosaccharide cannot reach the lumen and be matured or transferred to proteins, stalling the entire N-glycosylation pathway (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=N,The%20human%20RFT1%20protein">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=topologically%20distinct,to%20the%20asparagine%20residue%20of">pmc.ncbi.nlm.nih.gov</a>). </p>
<p><strong>Key Concept ‚Äì Lipid-Linked Oligosaccharide Flipping:</strong> RFT1 specifically translocates the <em>Man<sub>5</sub>GlcNAc<sub>2</em>-PP-dolichol intermediate across the ER membrane. Genetic studies first implicated RFT1 in this process (Helenius <em>et al.</em>, 2002) when yeast lacking Rft1 accumulated the intermediate and failed to complete glycosylation (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=identified%20Rft1%20by%20yeast%20genetics,vitro%20flipping%20assay%20using%20proteoliposomes">pmc.ncbi.nlm.nih.gov</a>). Correspondingly, when the human RFT1 gene is nonfunctional, cells also accumulate Man<sub>5</sub>GlcNAc<sub>2&gt;-PP-dolichol on the cytosolic side, underscoring that the flipping step is blocked (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=N,The%20human%20RFT1%20protein">pmc.ncbi.nlm.nih.gov</a>). Biochemically, this flipping is <em>ATP-independent</em> ‚Äì RFT1 acts as a lipid <em>scramblase</em> that facilitates the equilibrative movement of the glycolipid between membrane leaflets (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11365447/#:~:text=the%20necessary%20glycosyltransferases%20are%20known%2C,glycosylation%20underlie">pmc.ncbi.nlm.nih.gov</a>). It exhibits high specificity for the dolichol-linked heptasaccharide, ensuring that this exact precursor (and not unrelated lipids) is efficiently translocated (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11365447/#:~:text=the%20necessary%20glycosyltransferases%20are%20known%2C,glycosylation%20underlie">pmc.ncbi.nlm.nih.gov</a>). After flipping by RFT1, the complete Glc<sub>3</sub>Man<sub>9</sub>GlcNAc<sub>2</sub> glycan is assembled in the lumen and then transferred en bloc to proteins by oligosaccharyltransferase (OST) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=topologically%20distinct,to%20the%20asparagine%20residue%20of">pmc.ncbi.nlm.nih.gov</a>). Thus, RFT1‚Äôs primary function is to enable the key translocation step that connects cytosolic and luminal phases of N-glycan assembly, a role conserved across eukaryotic life (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=identified%20Rft1%20by%20yeast%20genetics,vitro%20flipping%20assay%20using%20proteoliposomes">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=translocation%20and%20demonstrate%20that%20purified,Dol%20ER%20flippase">pmc.ncbi.nlm.nih.gov</a>).</p>
<h2 id="molecular-characteristics-and-localization-of-rft1">Molecular Characteristics and Localization of RFT1</h2>
<p>Human RFT1 (UniProt Q96AA3) is an ER-resident multi-pass membrane protein consisting of 541 amino acids. Both its N-terminus and C-terminus face the cytosolic side of the ER membrane (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11365447/#:~:text=Rft1%2C%20using%20yeast%20cells%20as,work%20on%20this%20enigmatic%20protein">pmc.ncbi.nlm.nih.gov</a>). Topology studies and predictive modeling indicate that RFT1 spans the membrane ~14 times, forming a complex transmembrane structure (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=Structure%20prediction%20by%20AlphaFold2%20,Scores%20range">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=F,7%20of%20the%2014%20TM">pmc.ncbi.nlm.nih.gov</a>). Notably, RFT1 has no confirmed glycosylation sites of its own (it is not <em>N</em>-glycosylated), consistent with an orientation where any luminal loops are short or inaccessible for glycan attachment (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11365447/#:~:text=Rft1%2C%20using%20yeast%20cells%20as,work%20on%20this%20enigmatic%20protein">pmc.ncbi.nlm.nih.gov</a>). The protein belongs to the <strong>RFT1 family</strong> (Pfam PF04506), an evolutionarily conserved family of ER proteins found in virtually all eukaryotes (from yeast to humans) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=identified%20Rft1%20by%20yeast%20genetics,vitro%20flipping%20assay%20using%20proteoliposomes">pmc.ncbi.nlm.nih.gov</a>). Despite low sequence identity between distant orthologs ‚Äì for example, human RFT1 shares only ~22% amino-acid identity with yeast Rft1 ‚Äì these proteins are functionally interchangeable, indicating strong conservation at the functional level (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=found%20to%20carry%20a%20homozygous,R67C">pmc.ncbi.nlm.nih.gov</a>). Experiments have shown that human RFT1 can complement an RFT1 deletion in yeast, restoring normal growth and glycosylation, whereas a disease-mutant form of human RFT1 cannot (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=found%20to%20carry%20a%20homozygous,restoration%20of%20normal%20glycosylation%20profiles">pmc.ncbi.nlm.nih.gov</a>). This cross-species complementation underscores that the <strong>core function of RFT1 has been preserved</strong> even if the primary sequences diverged significantly (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=found%20to%20carry%20a%20homozygous,restoration%20of%20normal%20glycosylation%20profiles">pmc.ncbi.nlm.nih.gov</a>).</p>
<p>At the structural level, recent analyses suggest that RFT1 adopts a fold reminiscent of the MOP superfamily of transporters (the <strong>Multidrug/Oligosaccharidyl-lipid/Polysaccharide</strong> flippase family) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=Both%20the%20AlphaFold2%20model%20and,MurJ%20lipid%20II%20flippases%20which">pmc.ncbi.nlm.nih.gov</a>). In fact, computational models (AlphaFold2, 2024) indicate RFT1‚Äôs transmembrane domain is organized into two symmetric halves (each ~7 TM helices) forming a hydrophilic central cavity (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=F,7%20of%20the%2014%20TM">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=match%20at%20L595%20potenqal%20%2858%E2%80%9361%29,Fig">pmc.ncbi.nlm.nih.gov</a>). This architecture is strikingly similar to known lipid flippases such as bacterial MurJ, which uses an alternating-access mechanism to flip lipid-linked peptidoglycan precursors (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=Both%20the%20AlphaFold2%20model%20and,MurJ%20lipid%20II%20flippases%20which">pmc.ncbi.nlm.nih.gov</a>). The RFT1 model appears in an inward-open conformation, with a water-exposed cavity facing the cytosol that likely accommodates the Man<sub>5</sub>GlcNAc<sub>2</sub>-PP-dolichol substrate (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=match%20at%20L595%20potenqal%20%2858%E2%80%9361%29,Fig">pmc.ncbi.nlm.nih.gov</a>). Key conserved residues line this cavity and are thought to mediate substrate binding and translocation (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=Both%20the%20AlphaFold2%20model%20and,MurJ%20lipid%20II%20flippases%20which">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=plays%20in%20N,work%20on%20this%20enigmatic%20protein">pmc.ncbi.nlm.nih.gov</a>). Notably, most missense mutations identified in patients with RFT1 deficiency cluster in these conserved regions of the protein, highlighting their importance for function (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=plays%20in%20N,work%20on%20this%20enigmatic%20protein">pmc.ncbi.nlm.nih.gov</a>). Together, these structural features support a model in which RFT1 ‚Äúgrabs‚Äù the heptasaccharide-pyrophosphate dolichol on the cytosolic side and swivels to release it on the luminal side ‚Äì a classic alternating-access transport mechanism analogous to other known lipid flippases (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=Both%20the%20AlphaFold2%20model%20and,MurJ%20lipid%20II%20flippases%20which">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=match%20at%20L595%20potenqal%20%2858%E2%80%9361%29,Fig">pmc.ncbi.nlm.nih.gov</a>). Consistent with this idea, purified RFT1 protein reconstituted into liposomes is sufficient to mediate flipping without any other ER factors, suggesting RFT1 alone forms the active translocation pore or channel for the lipid-linked oligosaccharide (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=complex,independent%20flippase">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=our%20results%20unequivocally%20support%20the,ER%20membrane%20during%20LLO%20biosynthesis">pmc.ncbi.nlm.nih.gov</a>). </p>
<p><strong>Cellular Localization:</strong> RFT1 is an integral membrane protein of the endoplasmic reticulum. Endogenous RFT1 localizes to the ER membrane where N-glycan assembly occurs (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11365447/#:~:text=Rft1%2C%20using%20yeast%20cells%20as,work%20on%20this%20enigmatic%20protein">pmc.ncbi.nlm.nih.gov</a>). It is not found in the plasma membrane or other organelles, as its function is tightly linked to the ER‚Äôs dolichol pathway. In mammalian cells, RFT1‚Äôs expression is essential for viability ‚Äì cells lacking RFT1 cannot survive due to failure of protein glycosylation (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11365447/#:~:text=including%20RFT1,a%20molecular%20characterization%20of%20human">pmc.ncbi.nlm.nih.gov</a>). Similarly, yeast <em>RFT1</em> is an essential gene under normal conditions (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=identified%20Rft1%20by%20yeast%20genetics,vitro%20flipping%20assay%20using%20proteoliposomes">pmc.ncbi.nlm.nih.gov</a>). (One notable exception is <em>Trypanosoma brucei</em>, a parasitic protozoan where RFT1 is surprisingly non-essential for growth (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=match%20at%20L104%20yeast%20cells%2C,date%2C%20the%20identity%20of%20the">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11365447/#:~:text=including%20RFT1,a%20molecular%20characterization%20of%20human">pmc.ncbi.nlm.nih.gov</a>). This organism appears to have an alternate mechanism or bypass for LLO flipping, as discussed below.) Overall, RFT1 predominantly resides in ER membranes and carries out its transporter function co-translationally as the LLO is synthesized, ensuring that glycan assembly can seamlessly continue on the luminal side.</p>
<h2 id="functional-evidence-and-mechanism-flipping-the-lipid-linked-oligosaccharide">Functional Evidence and Mechanism: Flipping the Lipid-Linked Oligosaccharide</h2>
<p>Biochemical and genetic evidence strongly indicate that RFT1‚Äôs <strong>primary substrate</strong> is the lipid-linked heptasaccharide <em>Man<sub>5</sub>GlcNAc<sub>2</sub>-PP-dolichol</em>. In a landmark human study (Haeuptle <em>et al.</em>, <strong>2008</strong>), a young patient was found to accumulate this exact intermediate in cells due to a defective RFT1 gene (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=N,The%20human%20RFT1%20protein">pmc.ncbi.nlm.nih.gov</a>). The accumulation of Man<sub>5</sub>GlcNAc<sub>2</sub>-PP-dolichol on the cytosolic side (with a corresponding shortage of fully assembled Glc<sub>3</sub>Man<sub>9</sub>GlcNAc<sub>2</sub> in the lumen) is a clear biochemical signature of a flipping blockade (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=N,The%20human%20RFT1%20protein">pmc.ncbi.nlm.nih.gov</a>). Restoring a functional RFT1 in these patient cells allowed the intermediate to be properly utilized and normal glycosylation to resume (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=shares%2022,defect%20establishes%20the%20functional%20conservation">pmc.ncbi.nlm.nih.gov</a>). This finding mirrors earlier yeast genetic studies (Helenius <em>et al.</em>, <strong>2002) in which <em>rft1</em> mutants accumulated the same heptasaccharide and could not complete N-glycosylation (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=identified%20Rft1%20by%20yeast%20genetics,vitro%20flipping%20assay%20using%20proteoliposomes">pmc.ncbi.nlm.nih.gov</a>). Together, these results established that </strong>RFT1 is required for translocating Man<sub>5</sub>GlcNAc<sub>2</sub>-PP-dolichol from the cytoplasmic to luminal ER leaflet**, a step that is indispensable for assembling the complete N-glycan precursor (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=N,The%20human%20RFT1%20protein">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=topologically%20distinct,to%20the%20asparagine%20residue%20of">pmc.ncbi.nlm.nih.gov</a>). Without RFT1, the downstream ER-localized glycosyltransferases (Alg3, Alg9, Alg12 for mannose and Alg6/8/10 for glucose additions) cannot access the substrate, leading to under-glycosylated proteins and severe cellular dysfunction (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=N,The%20human%20RFT1%20protein">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=severe%20mental%20retardation%2C%20hypotonia%2C%20epilepsy%2C,was%20found%20in%20all%20four">pmc.ncbi.nlm.nih.gov</a>). </p>
<p>Mechanistically, RFT1 appears to function as a <strong>selective scramblase</strong>. It does not hydrolyze ATP or use any obvious energy source; instead, it facilitates the flip-flop of the pyrophosphate-linked oligosaccharide down its concentration gradient in a highly selective manner (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11365447/#:~:text=the%20necessary%20glycosyltransferases%20are%20known%2C,glycosylation%20underlie">pmc.ncbi.nlm.nih.gov</a>). Early studies suggested the existence of an <em>ATP-independent flippase</em> activity in ER membranes specific for the LLO intermediate (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11365447/#:~:text=the%20necessary%20glycosyltransferases%20are%20known%2C,glycosylation%20underlie">pmc.ncbi.nlm.nih.gov</a>). RFT1 fits this profile: it likely lowers the energy barrier for the charged, bulky Man<sub>5</sub>GlcNAc<sub>2</sub>-PP-dolichol to traverse the hydrophobic membrane. Importantly, this specificity distinguishes RFT1 from general lipid scramblases that indiscriminately equilibrate lipids. In vitro assays have confirmed that RFT1 does <strong>not</strong> flip simpler lipid phosphates (like phosphatidylcholine) but <strong>does</strong> translocate the dolichol-linked oligosaccharide (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=complex,independent%20flippase">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=our%20results%20unequivocally%20support%20the,ER%20membrane%20during%20LLO%20biosynthesis">pmc.ncbi.nlm.nih.gov</a>). This agrees with the idea that RFT1‚Äôs transmembrane cavity is tailored to recognize the polyprenol-pyrophosphate glycan headgroup. Intriguingly, some evidence suggests RFT1 might also assist in flipping other lipid-linked glycans. For example, a study in <em>T. brucei</em> (Gottier <em>et al.</em>, <strong>2017</strong>) found that loss of RFT1 affected <strong>GPI anchor</strong> glycosylation, implying RFT1 may partake in translocation of the glycolipid intermediates of GPI anchor biosynthesis as well (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5247644/#:~:text=Skip%20to%20main%20content%20J,Serrano%20%5E%7B%E2%80%96%2C%7D%5E%7B%2A%2A%2C%7D%5E%7B1%7D%2C%20Peter%20B%C3%BCtikofer%20%5E%7B%E2%80%A1%2C%7D%5E%7B1%2C%7D%5E%7B2">pmc.ncbi.nlm.nih.gov</a>). While human RFT1‚Äôs involvement in GPI precursor flipping remains less clear, this observation raises the possibility that RFT1‚Äôs <strong>‚Äúsubstrate‚Äù could include multiple glycolipid types</strong> in organisms that lack alternative flippases. Nonetheless, the best-established and primary role of RFT1 in human cells is the flipping of the N-glycan lipid precursor Man<sub>5</sub>GlcNAc<sub>2</sub>-PP-Dol, a prerequisite for proper N-linked protein glycosylation (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=N,The%20human%20RFT1%20protein">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=our%20results%20unequivocally%20support%20the,ER%20membrane%20during%20LLO%20biosynthesis">pmc.ncbi.nlm.nih.gov</a>).</p>
<h2 id="historical-controversy-and-recent-advances-20232024">Historical Controversy and Recent Advances (2023‚Äì2024)</h2>
<p>For over two decades, the identity of the ER <strong>LLO flippase</strong> was a subject of debate (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=studies%20identified%20Rft1%20as%20the,We">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=identified%20Rft1%20by%20yeast%20genetics,vitro%20flipping%20assay%20using%20proteoliposomes">pmc.ncbi.nlm.nih.gov</a>). Initial <strong>genetic evidence</strong> in yeast (2002) and the first human case (2008) strongly pointed to RFT1 as the required flippase, since RFT1 loss caused the expected glycosylation defect in vivo (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=identified%20Rft1%20by%20yeast%20genetics,vitro%20flipping%20assay%20using%20proteoliposomes">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=N,The%20human%20RFT1%20protein">pmc.ncbi.nlm.nih.gov</a>). However, subsequent <strong>biochemical studies</strong> in 2008‚Äì2009 challenged this interpretation. In 2008, Menon and colleagues reconstituted ER membrane vesicles and reported that Man<sub>5</sub>GlcNAc<sub>2</sub>-PP-Dol flipping occurred even in the apparent absence of RFT1, suggesting ‚Äúa specific ER protein(s), <strong>but not Rft1,</strong> is required to flip‚Äù the LLO precursor (<a href="https://www.nature.com/articles/nature07165#:~:text=genetic%20evidence%20suggesting%20that%20Rft1%2C,itself%20remains%20to%20be%20identified">www.nature.com</a>). Similarly, a 2009 study by Rush <em>et al.</em> found that yeast microsomes with greatly reduced Rft1 still showed normal translocation of the heptasaccharide, implying redundant or RFT1-independent flipping activity (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=Dol,vitro%20flipping%20assay%20using%20proteoliposomes">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=match%20at%20L104%20yeast%20cells%2C,is%20not%20essential%20for%20at">pmc.ncbi.nlm.nih.gov</a>). These findings led to a hypothesis that RFT1 might play an <em>indirect or accessory role</em> (perhaps as a chaperone for the LLO or in maintaining membrane homeostasis) rather than being the flippase itself (<a href="https://www.nature.com/articles/nature07165#:~:text=that%20a%20specific%20ER%20protein,itself%20remains%20to%20be%20identified">www.nature.com</a>). The mystery deepened when Jelk <em>et al.</em> (2013) discovered that <em>Trypanosoma brucei</em> can survive without any RFT1, yet still glycosylate its proteins ‚Äì evidence that an alternate flippase exists in that organism (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=yeast%20cells%2C%20in%20which%20Rft1,date%2C%20the%20identity%20of%20the">pmc.ncbi.nlm.nih.gov</a>). By the mid-2010s, RFT1 was the only protein <strong>ever implicated</strong> in LLO translocation, but definitive proof of its direct role was lacking and many experts remained skeptical of its function (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=identified%20Rft1%20by%20yeast%20genetics,vitro%20flipping%20assay%20using%20proteoliposomes">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=match%20at%20L108%20flippase%20remains,Dol">pmc.ncbi.nlm.nih.gov</a>). Reviews of congenital glycosylation disorders even highlighted the ‚Äúenigmatic‚Äù nature of RFT1, noting that its essential role in most eukaryotes was clear despite the contradictory in vitro data (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=is%20essential%20for%20the%20viability,termini%20facing%20the">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11365447/#:~:text=including%20RFT1,a%20molecular%20characterization%20of%20human">pmc.ncbi.nlm.nih.gov</a>). </p>
<p><strong>Resolution ‚Äì Direct Flippase Proof:</strong> The long-standing controversy was resolved by new research in 2023‚Äì2024. In <strong>June 2024, a breakthrough study in <em>Nature Communications</em></strong> by Shuai Chen <em>et al.</em> provided unequivocal evidence that RFT1 <em>itself</em> catalyzes lipid-linked oligosaccharide flipping (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=our%20results%20unequivocally%20support%20the,ER%20membrane%20during%20LLO%20biosynthesis">pmc.ncbi.nlm.nih.gov</a>). The researchers purified RFT1 (from yeast and human) and reconstituted it into artificial liposomes, then monitored transport of a fluorescently labeled Man<sub>5</sub>GlcNAc<sub>2</sub>-PP-dolichol analog. They demonstrated that RFT1 alone is sufficient to translocate the oligosaccharide across the bilayer in vitro (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=complex,independent%20flippase">pmc.ncbi.nlm.nih.gov</a>). This work showed <strong>substrate specificity</strong> matching the in vivo requirements ‚Äì RFT1 robustly flipped the full pyrophosphate-linked heptasaccharide, whereas simpler dolichol-phosphate sugars were not transported (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=complex,independent%20flippase">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=f%29,independent%20flippase">pmc.ncbi.nlm.nih.gov</a>). In the same assays, an unrelated control protein could not substitute for RFT1, confirming the activity was intrinsic to RFT1. Notably, the <em>Nature Communications</em> study also tested an archaeal protein (Haloarcula <em>Agl23</em>) that had been discovered via a genetic suppressor screen: remarkably, Agl23 ‚Äì which has no sequence homology to RFT1 ‚Äì could flip the LLO intermediate just like RFT1 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=of%20M5GN2%20to%20M3GN2%20after,lipid%20bilayer%20of%20reconstituted%20liposomes">pmc.ncbi.nlm.nih.gov</a>). Agl23 had been found capable of rescuing yeast lacking RFT1, and in the reconstituted system it, too, catalyzed efficient flipping of Man<sub>5</sub>GlcNAc<sub>2</sub>-PP-dolichol (or a polyprenol analog) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=of%20M5GN2%20to%20M3GN2%20after,lipid%20bilayer%20of%20reconstituted%20liposomes">pmc.ncbi.nlm.nih.gov</a>). This provided independent validation that flipping can be accomplished by at least two structurally distinct proteins, underscoring that it is <em>flippase activity</em> per se that is critical, whether provided by RFT1 or a surrogate (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=of%20M5GN2%20to%20M3GN2%20after,lipid%20bilayer%20of%20reconstituted%20liposomes">pmc.ncbi.nlm.nih.gov</a>). Together, these results <strong>‚Äúunequivocally support the idea that Rft1, from both yeast and human, is directly responsible‚Äù</strong> for translocating the LLO intermediate in eukaryotic cells (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=our%20results%20unequivocally%20support%20the,ER%20membrane%20during%20LLO%20biosynthesis">pmc.ncbi.nlm.nih.gov</a>). </p>
<p>Concurrently, other researchers have solidified our understanding of RFT1‚Äôs structure-function. In <strong>July 2024, a study in <em>Journal of Biological Chemistry</em></strong> (Hirata <em>et al.</em>, 2024) provided a detailed molecular characterization of human RFT1 using yeast as a model system (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11365447/#:~:text=including%20RFT1,its%20N%20and%20C%20termini">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11365447/#:~:text=Rft1%2C%20using%20yeast%20cells%20as,work%20on%20this%20enigmatic%20protein">pmc.ncbi.nlm.nih.gov</a>). This work confirmed that RFT1 is a multi-spanning ER protein with no glycosylation, and identified several critical residues required for its function by testing mutant variants in yeast (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=plays%20in%20N,work%20on%20this%20enigmatic%20protein">pmc.ncbi.nlm.nih.gov</a>). The JBC study‚Äôs structural analysis reinforced the similarity between RFT1 and bacterial flippases like MurJ, lending a strong theoretical framework for <em>how</em> RFT1 works (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=Both%20the%20AlphaFold2%20model%20and,MurJ%20lipid%20II%20flippases%20which">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=match%20at%20L595%20potenqal%20%2858%E2%80%9361%29,Fig">pmc.ncbi.nlm.nih.gov</a>). With modern tools, the authors could finally reconcile the old discrepancies: they suggested that earlier in vitro assays likely had unidentified ER scramblases keeping partial flipping activity in RFT1-depleted preparations, whereas the 2024 reconstitution used highly purified components to attribute activity specifically to RFT1 (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=Dol,vitro%20flipping%20assay%20using%20proteoliposomes">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=complex,independent%20flippase">pmc.ncbi.nlm.nih.gov</a>). In summary, as of 2024, consensus has been reached that <strong>RFT1 is the bona fide ER flippase for the N-glycan precursor</strong>, resolving a decades-long question in cell biology (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=our%20results%20unequivocally%20support%20the,ER%20membrane%20during%20LLO%20biosynthesis">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=translocation%20and%20demonstrate%20that%20purified,Dol%20ER%20flippase">pmc.ncbi.nlm.nih.gov</a>). This resolution fills an important gap in the canonical N-glycosylation pathway and is hailed as a significant advance in our understanding of membrane transport mechanisms in glycoprotein biosynthesis (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=translocation%20and%20demonstrate%20that%20purified,Dol%20ER%20flippase">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=our%20results%20unequivocally%20support%20the,ER%20membrane%20during%20LLO%20biosynthesis">pmc.ncbi.nlm.nih.gov</a>).</p>
<h2 id="clinical-significance-rft1-congenital-disorder-of-glycosylation-cdg-in">Clinical Significance: RFT1-Congenital Disorder of Glycosylation (CDG-In)</h2>
<p><strong>RFT1 deficiency</strong> in humans causes a severe congenital disorder of glycosylation, underscoring the protein‚Äôs indispensable role in vivo (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=series%20of%20ordered%20reactions%20requiring,the%20low%20sequence%20similarity%20between">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=match%20at%20L35%20protein,earlier%20reported%20RFT1%20missense%20mutation">pmc.ncbi.nlm.nih.gov</a>). The first patient with RFT1-CDG was reported in 2008 (an infant with a homozygous RFT1 missense mutation, p.R67C) and presented with a profound multisystem disease (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=series%20of%20ordered%20reactions%20requiring,the%20low%20sequence%20similarity%20between">pmc.ncbi.nlm.nih.gov</a>). Biochemical analysis of this patient‚Äôs cells revealed an intracellular build-up of Man<sub>5</sub>GlcNAc<sub>2</sub>-PP-dolichol and abnormally under-glycosylated serum glycoproteins, directly linking the RFT1 mutation to a defect in N-linked glycan assembly (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=N,The%20human%20RFT1%20protein">pmc.ncbi.nlm.nih.gov</a>). Expression of normal RFT1 cDNA in the patient‚Äôs fibroblasts rescued the glycosylation defect, proving causality of the RFT1 mutation (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=shares%2022,defect%20establishes%20the%20functional%20conservation">pmc.ncbi.nlm.nih.gov</a>). Following this discovery, a handful of additional cases were identified worldwide (three new cases were described by 2009), and the disorder has been designated <strong>‚ÄúRFT1-CDG‚Äù</strong> or <strong>CDG type I<em>n</em></strong> (CDG-In, in the original nomenclature) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=protein.%20Recently%2C%20the%20first%20RFT1,earlier%20reported%20RFT1%20missense%20mutation">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=match%20at%20L99%20for%20RFT1,Jaeken%20et%20al.%2C%202008">pmc.ncbi.nlm.nih.gov</a>). RFT1-CDG is inherited in an autosomal recessive manner and is extremely rare ‚Äì only a few families have been documented in the literature (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=protein.%20Recently%2C%20the%20first%20RFT1,earlier%20reported%20RFT1%20missense%20mutation">pmc.ncbi.nlm.nih.gov</a>). </p>
<p>Clinically, RFT1-CDG patients exhibit the hallmark features of many N-glycosylation disorders, combined with some distinctive symptoms. Infants typically show failure to thrive, hypotonia (low muscle tone), and developmental delays from early on (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=severe%20mental%20retardation%2C%20hypotonia%2C%20epilepsy%2C,was%20found%20in%20all%20four">pmc.ncbi.nlm.nih.gov</a>). Neurological problems are prominent, including seizures or myoclonic jerks and intellectual disability (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=severe%20mental%20retardation%2C%20hypotonia%2C%20epilepsy%2C,was%20found%20in%20all%20four">pmc.ncbi.nlm.nih.gov</a>). Organ systems such as the liver and gut can be affected, and dysmorphic features or skeletal abnormalities are sometimes noted, reflecting the systemic importance of glycoproteins (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=severe%20mental%20retardation%2C%20hypotonia%2C%20epilepsy%2C,was%20found%20in%20all%20four">pmc.ncbi.nlm.nih.gov</a>). Strikingly, <strong>sensorineural deafness</strong> has been observed in all reported RFT1-CDG patients ‚Äì an unusual feature not seen in most other CDG subtypes (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=severe%20mental%20retardation%2C%20hypotonia%2C%20epilepsy%2C,was%20found%20in%20all%20four">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=phenotype%20of%20these%20patients%20comprised,crucial%20role%20of%20RFT1%20in">pmc.ncbi.nlm.nih.gov</a>). This consistent deafness, alongside the severe neurodevelopmental impairment, suggests that certain cell types (e.g. inner ear neurons and brain cells) are especially sensitive to defects in the LLO flipping step (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=phenotype%20of%20these%20patients%20comprised,crucial%20role%20of%20RFT1%20in">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=comparison%20to%20other%20CDG%20defects%2C,because%20deafness%20has%20been%20reported">pmc.ncbi.nlm.nih.gov</a>). Indeed, researchers have noted that RFT1-CDG is ‚Äúmainly a neurological disorder,‚Äù with the ear pathology as a notable clue (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=phenotype%20of%20these%20patients%20comprised,crucial%20role%20of%20RFT1%20in">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=comparison%20to%20other%20CDG%20defects%2C,because%20deafness%20has%20been%20reported">pmc.ncbi.nlm.nih.gov</a>). There is currently no cure for RFT1-CDG; management is supportive and focuses on treating symptoms (for example, anti-seizure medications and nutritional support). Early death in childhood is common in the severe cases reported (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=severe%20mental%20retardation%2C%20hypotonia%2C%20epilepsy%2C,was%20found%20in%20all%20four">pmc.ncbi.nlm.nih.gov</a>). The identification of RFT1-CDG has, however, enabled genetic diagnosis for affected families. RFT1 gene sequencing is now included in CDG diagnostic panels (listed as <strong>CDG-1N</strong> in genetic testing registries) (<a href="https://www.ncbi.nlm.nih.gov/gtr/conditions/C2677590#:~:text=Warning%3A%20The%20NCBI%20web%20site,Orphanet">www.ncbi.nlm.nih.gov</a>). This allows for carrier testing and prenatal diagnosis, which are important given the recessive inheritance and high medical burden of the disease. RFT1-CDG is one of more than 30 known genetic defects in the N-linked glycosylation pathway (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11365447/#:~:text=numerous%20human%20genetic%20disorders%20including,glycoproteins%20in%20the%20ER">pmc.ncbi.nlm.nih.gov</a>), and each such discovery (RFT1 included) has provided valuable insight into human glycan biosynthesis. In particular, RFT1-CDG cases offered <em>in vivo</em> confirmation that the Man<sub>5</sub>GlcNAc<sub>2</sub>-PP-Dol flippase step is critically important for human development (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=N,The%20human%20RFT1%20protein">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=series%20of%20ordered%20reactions%20requiring,the%20low%20sequence%20similarity%20between">pmc.ncbi.nlm.nih.gov</a>). </p>
<h2 id="current-applications-and-future-directions">Current Applications and Future Directions</h2>
<p>The elucidation of RFT1‚Äôs function has several important applications in biomedicine and biotechnology. <strong>Diagnostic Medicine:</strong> As described above, knowing the molecular basis of RFT1-CDG allows clinicians to diagnose this disorder via genetic testing and abnormal glycosylation screening (e.g. transferrin isoform analysis) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=Congenital%20disorders%20of%20glycosylation%20,sialotransferrin%20pattern%20is%20the%20most">pmc.ncbi.nlm.nih.gov</a>). For families affected by RFT1-CDG, genetic counseling and early intervention become possible now that the gene is identified. Moreover, RFT1-CDG stands as a model for developing therapies for glycosylation disorders. One experimental approach demonstrated in 2008 was to use a lentiviral vector expressing wild-type RFT1 to ‚Äúcure‚Äù patient cells in culture (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=shares%2022,defect%20establishes%20the%20functional%20conservation">pmc.ncbi.nlm.nih.gov</a>). This gene therapy concept ‚Äì replacing the defective flippase gene ‚Äì successfully restored normal glycan profiles in vitro (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=orthology%20and%20the%20pathologic%20effect,defect%20establishes%20the%20functional%20conservation">pmc.ncbi.nlm.nih.gov</a>). While actual gene therapy in patients would face significant hurdles, this result provides a proof-of-principle that correcting the flip defect can rescue cell function. As gene delivery techniques improve, RFT1 might be considered a candidate for future gene therapy trials in CDG (especially if a patient presents with a milder, partially active mutation that could be complemented). Additionally, understanding RFT1‚Äôs activity enables screening for small molecules or pharmacological chaperones that might stabilize certain mutant RFT1 proteins. If a partial loss-of-function mutant is misfolded, a drug that improves its folding could restore some flipping activity ‚Äì a strategy being explored for other protein-misfolding CDGs (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=Congenital%20disorders%20of%20glycosylation%20,sialotransferrin%20pattern%20is%20the%20most">pmc.ncbi.nlm.nih.gov</a>).</p>
<p><strong>Research and Biotechnology:</strong> The definitive identification of RFT1 as the LLO flippase also has practical implications for research and bioengineering. In glycobiology research, the availability of an in vitro flipping assay (thanks to purified RFT1 reconstitution) is a significant advancement (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=complex,independent%20flippase">pmc.ncbi.nlm.nih.gov</a>). This assay can be used to interrogate the mechanism of translocation in detail ‚Äì for instance, to determine how fast RFT1 flips the lipid, whether any ion gradients or membrane conditions modulate its activity, and whether accessory proteins influence efficiency. It also opens the door to high-resolution structural studies (e.g. cryo-EM efforts) now that a functional preparation of RFT1 is in hand. Early modeling suggests RFT1 operates via an alternating-access mechanism (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=match%20at%20L595%20potenqal%20%2858%E2%80%9361%29,Fig">pmc.ncbi.nlm.nih.gov</a>), and future studies may capture different conformational states of RFT1 or even co-complexes with the LLO substrate. Such structural insights could be invaluable for rational drug design if one ever aims to modulate N-glycosylation (for example, tweaking glycan profiles in biotech production of therapeutic glycoproteins). In biotechnology, engineering robust N-glycosylation pathways in non-native systems (like yeast or microalgae used to produce recombinant proteins) requires a functional flippase. The confirmation that RFT1 is the required flippase means that any glyco-engineering effort must ensure RFT1 (or an equivalent activity) is present. Indeed, the discovery that an archaeal protein (Agl23) can substitute for RFT1‚Äôs function (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=of%20M5GN2%20to%20M3GN2%20after,lipid%20bilayer%20of%20reconstituted%20liposomes">pmc.ncbi.nlm.nih.gov</a>) hints that there may be bioengineered solutions to bypass defects or optimize glycosylation. For instance, if a particular production strain has low endogenous flipping efficiency, introducing a more efficient flippase (perhaps a variant or a surrogate from another species) might enhance glycoprotein yield or fidelity. </p>
<p>Finally, RFT1‚Äôs study has broader significance in cell biology. It exemplifies how cells handle hydrophilic substrates within membranes and has stimulated comparisons to other lipid transport processes. The knowledge gained from RFT1 is informing research on analogous systems, such as flippases for GPI anchors and other glycolipids. As noted, RFT1 may not act entirely alone in living cells ‚Äì there could be a network of membrane proteins ensuring all kinds of lipid-linked sugars are properly oriented. By studying RFT1, scientists are also learning how membrane topology and protein machinery co-evolved to manage complex lipid-linked reactions. In summary, the current understanding of RFT1 ‚Äì solidified by recent research ‚Äì not only <em>completes the puzzle</em> of the N-linked glycosylation pathway but also provides a foundation for medical and biotechnological advances. This ER transporter, once controversial, is now recognized as a crucial enzyme-like protein that bridges two phases of glycan assembly, with real-world impacts from diagnosing rare diseases to potentially improving biomanufacturing of glycoproteins. The ongoing research and expert analyses uniformly highlight RFT1 as <strong>‚Äúthe‚Äù Man<sub>5</sub>GlcNAc<sub>2</sub>-PP-Dol flippase</strong> in eukaryotes (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=our%20results%20unequivocally%20support%20the,ER%20membrane%20during%20LLO%20biosynthesis">pmc.ncbi.nlm.nih.gov</a>), reflecting a consensus built on decades of study and culminating in the latest findings of 2024. </p>
<p><strong>References:</strong> Recent authoritative sources supporting this report include <em>Nature Communications</em> (June 17, 2024) which provided direct biochemical evidence for RFT1‚Äôs flippase activity (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=our%20results%20unequivocally%20support%20the,ER%20membrane%20during%20LLO%20biosynthesis">pmc.ncbi.nlm.nih.gov</a>), and <em>J. Biol. Chem.</em> (July 2024) which detailed RFT1‚Äôs structure-function characteristics (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=Both%20the%20AlphaFold2%20model%20and,MurJ%20lipid%20II%20flippases%20which">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11365447/#:~:text=Rft1%2C%20using%20yeast%20cells%20as,work%20on%20this%20enigmatic%20protein">pmc.ncbi.nlm.nih.gov</a>). Foundational studies in <em>Nature</em> (Helenius <em>et al.</em>, 2002) first implicated RFT1 in LLO translocation (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=identified%20Rft1%20by%20yeast%20genetics,vitro%20flipping%20assay%20using%20proteoliposomes">pmc.ncbi.nlm.nih.gov</a>), while an <em>Am. J. Hum. Genet.</em> paper (Feb 2008) identified RFT1 mutations in CDG patients (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=series%20of%20ordered%20reactions%20requiring,the%20low%20sequence%20similarity%20between">pmc.ncbi.nlm.nih.gov</a>). The back-and-forth debate in the literature (e.g. Frank <em>et al.</em>, <em>Nature</em> 2008 (<a href="https://www.nature.com/articles/nature07165#:~:text=genetic%20evidence%20suggesting%20that%20Rft1%2C,itself%20remains%20to%20be%20identified">www.nature.com</a>), and subsequent discussions) has now been put to rest by the convergence of genetic, clinical, and biochemical data. These sources, along with others cited throughout this report, provide a comprehensive, up-to-date view of RFT1‚Äôs function, importance, and emerging applications.</p>
<h2 id="citations">Citations</h2>
<ol>
<li>AnnotationURLCitation(end_index=464, start_index=326, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=Asparagine%20%28N%29,P%2C%20GlcNAc%20and%20five%20Man')</li>
<li>AnnotationURLCitation(end_index=799, start_index=659, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=Glc3Man9GlcNAc2%20,to%20the%20asparagine%20residue%20of')</li>
<li>AnnotationURLCitation(end_index=1200, start_index=1054, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=topologically%20distinct,to%20the%20asparagine%20residue%20of')</li>
<li>AnnotationURLCitation(end_index=1548, start_index=1402, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=topologically%20distinct,to%20the%20asparagine%20residue%20of')</li>
<li>AnnotationURLCitation(end_index=1926, start_index=1749, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=identified%20Rft1%20by%20yeast%20genetics,vitro%20flipping%20assay%20using%20proteoliposomes')</li>
<li>AnnotationURLCitation(end_index=2073, start_index=1927, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=topologically%20distinct,to%20the%20asparagine%20residue%20of')</li>
<li>AnnotationURLCitation(end_index=2456, start_index=2300, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=translocation%20and%20demonstrate%20that%20purified,Dol%20ER%20flippase')</li>
<li>AnnotationURLCitation(end_index=2603, start_index=2457, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=topologically%20distinct,to%20the%20asparagine%20residue%20of')</li>
<li>AnnotationURLCitation(end_index=2886, start_index=2772, title='Human RFT1 Deficiency Leads to a Disorder of N-Linked Glycosylation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=N,The%20human%20RFT1%20protein')</li>
<li>AnnotationURLCitation(end_index=3033, start_index=2887, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=topologically%20distinct,to%20the%20asparagine%20residue%20of')</li>
<li>AnnotationURLCitation(end_index=3555, start_index=3378, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=identified%20Rft1%20by%20yeast%20genetics,vitro%20flipping%20assay%20using%20proteoliposomes')</li>
<li>AnnotationURLCitation(end_index=3864, start_index=3750, title='Human RFT1 Deficiency Leads to a Disorder of N-Linked Glycosylation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=N,The%20human%20RFT1%20protein')</li>
<li>AnnotationURLCitation(end_index=4205, start_index=4040, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11365447/#:~:text=the%20necessary%20glycosyltransferases%20are%20known%2C,glycosylation%20underlie')</li>
<li>AnnotationURLCitation(end_index=4532, start_index=4367, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11365447/#:~:text=the%20necessary%20glycosyltransferases%20are%20known%2C,glycosylation%20underlie')</li>
<li>AnnotationURLCitation(end_index=4875, start_index=4729, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=topologically%20distinct,to%20the%20asparagine%20residue%20of')</li>
<li>AnnotationURLCitation(end_index=5229, start_index=5052, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=identified%20Rft1%20by%20yeast%20genetics,vitro%20flipping%20assay%20using%20proteoliposomes')</li>
<li>AnnotationURLCitation(end_index=5386, start_index=5230, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=translocation%20and%20demonstrate%20that%20purified,Dol%20ER%20flippase')</li>
<li>AnnotationURLCitation(end_index=5788, start_index=5628, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11365447/#:~:text=Rft1%2C%20using%20yeast%20cells%20as,work%20on%20this%20enigmatic%20protein')</li>
<li>AnnotationURLCitation(end_index=6065, start_index=5922, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=Structure%20prediction%20by%20AlphaFold2%20,Scores%20range')</li>
<li>AnnotationURLCitation(end_index=6175, start_index=6066, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=F,7%20of%20the%2014%20TM')</li>
<li>AnnotationURLCitation(end_index=6532, start_index=6372, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11365447/#:~:text=Rft1%2C%20using%20yeast%20cells%20as,work%20on%20this%20enigmatic%20protein')</li>
<li>AnnotationURLCitation(end_index=6877, start_index=6700, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=identified%20Rft1%20by%20yeast%20genetics,vitro%20flipping%20assay%20using%20proteoliposomes')</li>
<li>AnnotationURLCitation(end_index=7244, start_index=7120, title='Human RFT1 Deficiency Leads to a Disorder of N-Linked Glycosylation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=found%20to%20carry%20a%20homozygous,R67C')</li>
<li>AnnotationURLCitation(end_index=7593, start_index=7421, title='Human RFT1 Deficiency Leads to a Disorder of N-Linked Glycosylation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=found%20to%20carry%20a%20homozygous,restoration%20of%20normal%20glycosylation%20profiles')</li>
<li>AnnotationURLCitation(end_index=7921, start_index=7749, title='Human RFT1 Deficiency Leads to a Disorder of N-Linked Glycosylation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=found%20to%20carry%20a%20homozygous,restoration%20of%20normal%20glycosylation%20profiles')</li>
<li>AnnotationURLCitation(end_index=8282, start_index=8122, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=Both%20the%20AlphaFold2%20model%20and,MurJ%20lipid%20II%20flippases%20which')</li>
<li>AnnotationURLCitation(end_index=8576, start_index=8467, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=F,7%20of%20the%2014%20TM')</li>
<li>AnnotationURLCitation(end_index=8716, start_index=8577, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=match%20at%20L595%20potenqal%20%2858%E2%80%9361%29,Fig')</li>
<li>AnnotationURLCitation(end_index=9056, start_index=8896, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=Both%20the%20AlphaFold2%20model%20and,MurJ%20lipid%20II%20flippases%20which')</li>
<li>AnnotationURLCitation(end_index=9384, start_index=9245, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=match%20at%20L595%20potenqal%20%2858%E2%80%9361%29,Fig')</li>
<li>AnnotationURLCitation(end_index=9649, start_index=9489, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=Both%20the%20AlphaFold2%20model%20and,MurJ%20lipid%20II%20flippases%20which')</li>
<li>AnnotationURLCitation(end_index=9788, start_index=9650, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=plays%20in%20N,work%20on%20this%20enigmatic%20protein')</li>
<li>AnnotationURLCitation(end_index=10099, start_index=9961, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=plays%20in%20N,work%20on%20this%20enigmatic%20protein')</li>
<li>AnnotationURLCitation(end_index=10538, start_index=10378, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=Both%20the%20AlphaFold2%20model%20and,MurJ%20lipid%20II%20flippases%20which')</li>
<li>AnnotationURLCitation(end_index=10678, start_index=10539, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=match%20at%20L595%20potenqal%20%2858%E2%80%9361%29,Fig')</li>
<li>AnnotationURLCitation(end_index=11043, start_index=10928, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=complex,independent%20flippase')</li>
<li>AnnotationURLCitation(end_index=11218, start_index=11044, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=our%20results%20unequivocally%20support%20the,ER%20membrane%20during%20LLO%20biosynthesis')</li>
<li>AnnotationURLCitation(end_index=11552, start_index=11392, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11365447/#:~:text=Rft1%2C%20using%20yeast%20cells%20as,work%20on%20this%20enigmatic%20protein')</li>
<li>AnnotationURLCitation(end_index=11966, start_index=11819, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11365447/#:~:text=including%20RFT1,a%20molecular%20characterization%20of%20human')</li>
<li>AnnotationURLCitation(end_index=12214, start_index=12037, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=identified%20Rft1%20by%20yeast%20genetics,vitro%20flipping%20assay%20using%20proteoliposomes')</li>
<li>AnnotationURLCitation(end_index=12495, start_index=12338, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=match%20at%20L104%20yeast%20cells%2C,date%2C%20the%20identity%20of%20the')</li>
<li>AnnotationURLCitation(end_index=12643, start_index=12496, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11365447/#:~:text=including%20RFT1,a%20molecular%20characterization%20of%20human')</li>
<li>AnnotationURLCitation(end_index=13487, start_index=13373, title='Human RFT1 Deficiency Leads to a Disorder of N-Linked Glycosylation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=N,The%20human%20RFT1%20protein')</li>
<li>AnnotationURLCitation(end_index=13860, start_index=13746, title='Human RFT1 Deficiency Leads to a Disorder of N-Linked Glycosylation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=N,The%20human%20RFT1%20protein')</li>
<li>AnnotationURLCitation(end_index=14147, start_index=13997, title='Human RFT1 Deficiency Leads to a Disorder of N-Linked Glycosylation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=shares%2022,defect%20establishes%20the%20functional%20conservation')</li>
<li>AnnotationURLCitation(end_index=14505, start_index=14328, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=identified%20Rft1%20by%20yeast%20genetics,vitro%20flipping%20assay%20using%20proteoliposomes')</li>
<li>AnnotationURLCitation(end_index=14867, start_index=14753, title='Human RFT1 Deficiency Leads to a Disorder of N-Linked Glycosylation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=N,The%20human%20RFT1%20protein')</li>
<li>AnnotationURLCitation(end_index=15014, start_index=14868, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=topologically%20distinct,to%20the%20asparagine%20residue%20of')</li>
<li>AnnotationURLCitation(end_index=15361, start_index=15247, title='Human RFT1 Deficiency Leads to a Disorder of N-Linked Glycosylation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=N,The%20human%20RFT1%20protein')</li>
<li>AnnotationURLCitation(end_index=15537, start_index=15362, title='RFT1 Deficiency in Three Novel CDG Patients - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=severe%20mental%20retardation%2C%20hypotonia%2C%20epilepsy%2C,was%20found%20in%20all%20four')</li>
<li>AnnotationURLCitation(end_index=15982, start_index=15817, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11365447/#:~:text=the%20necessary%20glycosyltransferases%20are%20known%2C,glycosylation%20underlie')</li>
<li>AnnotationURLCitation(end_index=16279, start_index=16114, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11365447/#:~:text=the%20necessary%20glycosyltransferases%20are%20known%2C,glycosylation%20underlie')</li>
<li>AnnotationURLCitation(end_index=16857, start_index=16742, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=complex,independent%20flippase')</li>
<li>AnnotationURLCitation(end_index=17032, start_index=16858, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=our%20results%20unequivocally%20support%20the,ER%20membrane%20during%20LLO%20biosynthesis')</li>
<li>AnnotationURLCitation(end_index=17749, start_index=17503, title='RFT1 Protein Affects Glycosylphosphatidylinositol (GPI) Anchor Glycosylation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC5247644/#:~:text=Skip%20to%20main%20content%20J,Serrano%20%5E%7B%E2%80%96%2C%7D%5E%7B%2A%2A%2C%7D%5E%7B1%7D%2C%20Peter%20B%C3%BCtikofer%20%5E%7B%E2%80%A1%2C%7D%5E%7B1%2C%7D%5E%7B2')</li>
<li>AnnotationURLCitation(end_index=18317, start_index=18203, title='Human RFT1 Deficiency Leads to a Disorder of N-Linked Glycosylation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=N,The%20human%20RFT1%20protein')</li>
<li>AnnotationURLCitation(end_index=18492, start_index=18318, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=our%20results%20unequivocally%20support%20the,ER%20membrane%20during%20LLO%20biosynthesis')</li>
<li>AnnotationURLCitation(end_index=18767, start_index=18641, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=studies%20identified%20Rft1%20as%20the,We')</li>
<li>AnnotationURLCitation(end_index=18945, start_index=18768, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=identified%20Rft1%20by%20yeast%20genetics,vitro%20flipping%20assay%20using%20proteoliposomes')</li>
<li>AnnotationURLCitation(end_index=19317, start_index=19140, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=identified%20Rft1%20by%20yeast%20genetics,vitro%20flipping%20assay%20using%20proteoliposomes')</li>
<li>AnnotationURLCitation(end_index=19432, start_index=19318, title='Human RFT1 Deficiency Leads to a Disorder of N-Linked Glycosylation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=N,The%20human%20RFT1%20protein')</li>
<li>AnnotationURLCitation(end_index=19958, start_index=19798, title='Does Rft1 flip an N-glycan lipid precursor? | Nature', type='url_citation', url='https://www.nature.com/articles/nature07165#:~:text=genetic%20evidence%20suggesting%20that%20Rft1%2C,itself%20remains%20to%20be%20identified')</li>
<li>AnnotationURLCitation(end_index=20309, start_index=20170, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=Dol,vitro%20flipping%20assay%20using%20proteoliposomes')</li>
<li>AnnotationURLCitation(end_index=20463, start_index=20310, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=match%20at%20L104%20yeast%20cells%2C,is%20not%20essential%20for%20at')</li>
<li>AnnotationURLCitation(end_index=20813, start_index=20667, title='Does Rft1 flip an N-glycan lipid precursor? | Nature', type='url_citation', url='https://www.nature.com/articles/nature07165#:~:text=that%20a%20specific%20ER%20protein,itself%20remains%20to%20be%20identified')</li>
<li>AnnotationURLCitation(end_index=21183, start_index=21026, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=yeast%20cells%2C%20in%20which%20Rft1,date%2C%20the%20identity%20of%20the')</li>
<li>AnnotationURLCitation(end_index=21552, start_index=21375, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=identified%20Rft1%20by%20yeast%20genetics,vitro%20flipping%20assay%20using%20proteoliposomes')</li>
<li>AnnotationURLCitation(end_index=21680, start_index=21553, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=match%20at%20L108%20flippase%20remains,Dol')</li>
<li>AnnotationURLCitation(end_index=22023, start_index=21877, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=is%20essential%20for%20the%20viability,termini%20facing%20the')</li>
<li>AnnotationURLCitation(end_index=22171, start_index=22024, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11365447/#:~:text=including%20RFT1,a%20molecular%20characterization%20of%20human')</li>
<li>AnnotationURLCitation(end_index=22648, start_index=22474, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=our%20results%20unequivocally%20support%20the,ER%20membrane%20during%20LLO%20biosynthesis')</li>
<li>AnnotationURLCitation(end_index=23083, start_index=22968, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=complex,independent%20flippase')</li>
<li>AnnotationURLCitation(end_index=23411, start_index=23296, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=complex,independent%20flippase')</li>
<li>AnnotationURLCitation(end_index=23524, start_index=23412, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=f%29,independent%20flippase')</li>
<li>AnnotationURLCitation(end_index=24080, start_index=23915, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=of%20M5GN2%20to%20M3GN2%20after,lipid%20bilayer%20of%20reconstituted%20liposomes')</li>
<li>AnnotationURLCitation(end_index=24452, start_index=24287, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=of%20M5GN2%20to%20M3GN2%20after,lipid%20bilayer%20of%20reconstituted%20liposomes')</li>
<li>AnnotationURLCitation(end_index=24847, start_index=24682, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=of%20M5GN2%20to%20M3GN2%20after,lipid%20bilayer%20of%20reconstituted%20liposomes')</li>
<li>AnnotationURLCitation(end_index=25205, start_index=25031, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=our%20results%20unequivocally%20support%20the,ER%20membrane%20during%20LLO%20biosynthesis')</li>
<li>AnnotationURLCitation(end_index=25612, start_index=25483, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11365447/#:~:text=including%20RFT1,its%20N%20and%20C%20termini')</li>
<li>AnnotationURLCitation(end_index=25773, start_index=25613, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11365447/#:~:text=Rft1%2C%20using%20yeast%20cells%20as,work%20on%20this%20enigmatic%20protein')</li>
<li>AnnotationURLCitation(end_index=26100, start_index=25962, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=plays%20in%20N,work%20on%20this%20enigmatic%20protein')</li>
<li>AnnotationURLCitation(end_index=26432, start_index=26272, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=Both%20the%20AlphaFold2%20model%20and,MurJ%20lipid%20II%20flippases%20which')</li>
<li>AnnotationURLCitation(end_index=26572, start_index=26433, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=match%20at%20L595%20potenqal%20%2858%E2%80%9361%29,Fig')</li>
<li>AnnotationURLCitation(end_index=27046, start_index=26907, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=Dol,vitro%20flipping%20assay%20using%20proteoliposomes')</li>
<li>AnnotationURLCitation(end_index=27162, start_index=27047, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=complex,independent%20flippase')</li>
<li>AnnotationURLCitation(end_index=27510, start_index=27336, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=our%20results%20unequivocally%20support%20the,ER%20membrane%20during%20LLO%20biosynthesis')</li>
<li>AnnotationURLCitation(end_index=27667, start_index=27511, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=translocation%20and%20demonstrate%20that%20purified,Dol%20ER%20flippase')</li>
<li>AnnotationURLCitation(end_index=28027, start_index=27871, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=translocation%20and%20demonstrate%20that%20purified,Dol%20ER%20flippase')</li>
<li>AnnotationURLCitation(end_index=28202, start_index=28028, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=our%20results%20unequivocally%20support%20the,ER%20membrane%20during%20LLO%20biosynthesis')</li>
<li>AnnotationURLCitation(end_index=28595, start_index=28422, title='Human RFT1 Deficiency Leads to a Disorder of N-Linked Glycosylation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=series%20of%20ordered%20reactions%20requiring,the%20low%20sequence%20similarity%20between')</li>
<li>AnnotationURLCitation(end_index=28754, start_index=28596, title='RFT1 Deficiency in Three Novel CDG Patients - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=match%20at%20L35%20protein,earlier%20reported%20RFT1%20missense%20mutation')</li>
<li>AnnotationURLCitation(end_index=29093, start_index=28920, title='Human RFT1 Deficiency Leads to a Disorder of N-Linked Glycosylation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=series%20of%20ordered%20reactions%20requiring,the%20low%20sequence%20similarity%20between')</li>
<li>AnnotationURLCitation(end_index=29468, start_index=29354, title='Human RFT1 Deficiency Leads to a Disorder of N-Linked Glycosylation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=N,The%20human%20RFT1%20protein')</li>
<li>AnnotationURLCitation(end_index=29753, start_index=29603, title='Human RFT1 Deficiency Leads to a Disorder of N-Linked Glycosylation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=shares%2022,defect%20establishes%20the%20functional%20conservation')</li>
<li>AnnotationURLCitation(end_index=30166, start_index=29991, title='RFT1 Deficiency in Three Novel CDG Patients - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=protein.%20Recently%2C%20the%20first%20RFT1,earlier%20reported%20RFT1%20missense%20mutation')</li>
<li>AnnotationURLCitation(end_index=30308, start_index=30167, title='RFT1 Deficiency in Three Novel CDG Patients - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=match%20at%20L99%20for%20RFT1,Jaeken%20et%20al.%2C%202008')</li>
<li>AnnotationURLCitation(end_index=30623, start_index=30448, title='RFT1 Deficiency in Three Novel CDG Patients - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=protein.%20Recently%2C%20the%20first%20RFT1,earlier%20reported%20RFT1%20missense%20mutation')</li>
<li>AnnotationURLCitation(end_index=31048, start_index=30873, title='RFT1 Deficiency in Three Novel CDG Patients - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=severe%20mental%20retardation%2C%20hypotonia%2C%20epilepsy%2C,was%20found%20in%20all%20four')</li>
<li>AnnotationURLCitation(end_index=31328, start_index=31153, title='RFT1 Deficiency in Three Novel CDG Patients - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=severe%20mental%20retardation%2C%20hypotonia%2C%20epilepsy%2C,was%20found%20in%20all%20four')</li>
<li>AnnotationURLCitation(end_index=31685, start_index=31510, title='RFT1 Deficiency in Three Novel CDG Patients - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=severe%20mental%20retardation%2C%20hypotonia%2C%20epilepsy%2C,was%20found%20in%20all%20four')</li>
<li>AnnotationURLCitation(end_index=32010, start_index=31835, title='RFT1 Deficiency in Three Novel CDG Patients - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=severe%20mental%20retardation%2C%20hypotonia%2C%20epilepsy%2C,was%20found%20in%20all%20four')</li>
<li>AnnotationURLCitation(end_index=32172, start_index=32011, title='RFT1 Deficiency in Three Novel CDG Patients - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=phenotype%20of%20these%20patients%20comprised,crucial%20role%20of%20RFT1%20in')</li>
<li>AnnotationURLCitation(end_index=32548, start_index=32387, title='RFT1 Deficiency in Three Novel CDG Patients - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=phenotype%20of%20these%20patients%20comprised,crucial%20role%20of%20RFT1%20in')</li>
<li>AnnotationURLCitation(end_index=32718, start_index=32549, title='RFT1 Deficiency in Three Novel CDG Patients - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=comparison%20to%20other%20CDG%20defects%2C,because%20deafness%20has%20been%20reported')</li>
<li>AnnotationURLCitation(end_index=33004, start_index=32843, title='RFT1 Deficiency in Three Novel CDG Patients - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=phenotype%20of%20these%20patients%20comprised,crucial%20role%20of%20RFT1%20in')</li>
<li>AnnotationURLCitation(end_index=33174, start_index=33005, title='RFT1 Deficiency in Three Novel CDG Patients - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=comparison%20to%20other%20CDG%20defects%2C,because%20deafness%20has%20been%20reported')</li>
<li>AnnotationURLCitation(end_index=33579, start_index=33404, title='RFT1 Deficiency in Three Novel CDG Patients - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=severe%20mental%20retardation%2C%20hypotonia%2C%20epilepsy%2C,was%20found%20in%20all%20four')</li>
<li>AnnotationURLCitation(end_index=33922, start_index=33790, title='RFT1-congenital disorder of glycosylation - NIH Genetic Testing Registry (GTR) - NCBI', type='url_citation', url='https://www.ncbi.nlm.nih.gov/gtr/conditions/C2677590#:~:text=Warning%3A%20The%20NCBI%20web%20site,Orphanet')</li>
<li>AnnotationURLCitation(end_index=34329, start_index=34164, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11365447/#:~:text=numerous%20human%20genetic%20disorders%20including,glycoproteins%20in%20the%20ER')</li>
<li>AnnotationURLCitation(end_index=34718, start_index=34604, title='Human RFT1 Deficiency Leads to a Disorder of N-Linked Glycosylation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=N,The%20human%20RFT1%20protein')</li>
<li>AnnotationURLCitation(end_index=34892, start_index=34719, title='Human RFT1 Deficiency Leads to a Disorder of N-Linked Glycosylation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=series%20of%20ordered%20reactions%20requiring,the%20low%20sequence%20similarity%20between')</li>
<li>AnnotationURLCitation(end_index=35445, start_index=35270, title='RFT1 Deficiency in Three Novel CDG Patients - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=Congenital%20disorders%20of%20glycosylation%20,sialotransferrin%20pattern%20is%20the%20most')</li>
<li>AnnotationURLCitation(end_index=35953, start_index=35803, title='Human RFT1 Deficiency Leads to a Disorder of N-Linked Glycosylation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=shares%2022,defect%20establishes%20the%20functional%20conservation')</li>
<li>AnnotationURLCitation(end_index=36259, start_index=36077, title='Human RFT1 Deficiency Leads to a Disorder of N-Linked Glycosylation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=orthology%20and%20the%20pathologic%20effect,defect%20establishes%20the%20functional%20conservation')</li>
<li>AnnotationURLCitation(end_index=37168, start_index=36993, title='RFT1 Deficiency in Three Novel CDG Patients - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC3869400/#:~:text=Congenital%20disorders%20of%20glycosylation%20,sialotransferrin%20pattern%20is%20the%20most')</li>
<li>AnnotationURLCitation(end_index=37584, start_index=37469, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=complex,independent%20flippase')</li>
<li>AnnotationURLCitation(end_index=38201, start_index=38062, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=match%20at%20L595%20potenqal%20%2858%E2%80%9361%29,Fig')</li>
<li>AnnotationURLCitation(end_index=39110, start_index=38945, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=of%20M5GN2%20to%20M3GN2%20after,lipid%20bilayer%20of%20reconstituted%20liposomes')</li>
<li>AnnotationURLCitation(end_index=40875, start_index=40701, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=our%20results%20unequivocally%20support%20the,ER%20membrane%20during%20LLO%20biosynthesis')</li>
<li>AnnotationURLCitation(end_index=41338, start_index=41164, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=our%20results%20unequivocally%20support%20the,ER%20membrane%20during%20LLO%20biosynthesis')</li>
<li>AnnotationURLCitation(end_index=41590, start_index=41430, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11014557/#:~:text=Both%20the%20AlphaFold2%20model%20and,MurJ%20lipid%20II%20flippases%20which')</li>
<li>AnnotationURLCitation(end_index=41751, start_index=41591, title='Molecular characterization of Rft1, an ER membrane protein associated with congenital disorder of glycosylation RFT1-CDG - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11365447/#:~:text=Rft1%2C%20using%20yeast%20cells%20as,work%20on%20this%20enigmatic%20protein')</li>
<li>AnnotationURLCitation(end_index=42032, start_index=41855, title='Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC11182771/#:~:text=identified%20Rft1%20by%20yeast%20genetics,vitro%20flipping%20assay%20using%20proteoliposomes')</li>
<li>AnnotationURLCitation(end_index=42296, start_index=42123, title='Human RFT1 Deficiency Leads to a Disorder of N-Linked Glycosylation - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2427296/#:~:text=series%20of%20ordered%20reactions%20requiring,the%20low%20sequence%20similarity%20between')</li>
<li>AnnotationURLCitation(end_index=42538, start_index=42378, title='Does Rft1 flip an N-glycan lipid precursor? | Nature', type='url_citation', url='https://www.nature.com/articles/nature07165#:~:text=genetic%20evidence%20suggesting%20that%20Rft1%2C,itself%20remains%20to%20be%20identified')</li>
</ol>
            </div>
        </details>
        
    </div>
    

    <!-- YAML Preview Section -->
    <div class="section">
        <details class="yaml-preview">
            <summary>
                <h2 style="display: inline;">üìÑ View Raw YAML</h2>
            </summary>
            <div class="yaml-content">
                <pre><code>id: Q96AA3
gene_symbol: RFT1
product_type: PROTEIN
status: IN_PROGRESS
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: &gt;-
  RFT1 encodes the Man(5)GlcNAc(2)-PP-dolichol translocation protein, a multi-pass
  transmembrane protein of the endoplasmic reticulum that functions as a glycolipid
  flippase. It catalyzes the translocation of the lipid-linked oligosaccharide (LLO)
  intermediate M5GN2-PP-Dol from the cytosolic to the lumenal leaflet of the ER membrane,
  an essential step in the N-glycosylation pathway. RFT1 belongs to the MOP
  (multidrug/oligosaccharidyl-lipid/polysaccharide) transporter superfamily and contains
  approximately 12-14 transmembrane spans with both N- and C-termini facing the cytosol.
  The protein shows substrate selectivity for the M5 intermediate over shorter M3
  intermediates. Loss-of-function mutations cause RFT1-CDG (OMIM 612015), a severe
  congenital disorder of glycosylation characterized by neurodevelopmental abnormalities,
  epilepsy, and sensorineural deafness.
existing_annotations:
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: &gt;-
      IBA annotation for ER membrane localization is strongly supported by phylogenetic
      inference and multiple lines of experimental evidence. Human RFT1 shares functional
      orthology with yeast Rft1 (PMID:18313027), and the protein localizes throughout the
      ER with approximately 12-14 transmembrane spans. UniProt annotates subcellular
      location as &#34;Endoplasmic reticulum membrane; Multi-pass membrane protein.&#34;
    action: ACCEPT
    reason: &gt;-
      ER membrane localization is well-established as the core functional site for RFT1.
      The IBA annotation is consistent with direct experimental evidence from functional
      complementation studies and topology mapping.
    supported_by:
      - reference_id: PMID:18313027
        supporting_text: &#34;The definition of the RFT1 defect establishes the functional conservation of the DolPP-GlcNAc(2)Man(5) translocation process in eukaryotes.&#34;
      - reference_id: file:human/RFT1/RFT1-deep-research-falcon.md
        supporting_text: &#34;Human RFT1 localizes throughout the ER. DeepTMHMM and experimental tagging/topology mapping indicate ~14 transmembrane spans with both N- and C-termini facing the cytosol&#34;
- term:
    id: GO:0034203
    label: glycolipid translocation
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: &gt;-
      IBA annotation for glycolipid translocation accurately captures the core biological
      process of RFT1. This annotation is supported by phylogenetic inference and is
      consistent with direct biochemical evidence from Chen et al. 2024, which demonstrated
      that purified Rft1 catalyzes M5GN2-PP-Dol translocation across lipid bilayers.
    action: ACCEPT
    reason: &gt;-
      Glycolipid translocation is the primary biological process function of RFT1. The
      2024 reconstitution studies with purified protein definitively established this
      as the direct enzymatic function, resolving prior controversy about whether RFT1
      directly catalyzes translocation.
    supported_by:
      - reference_id: PMID:38886340
        supporting_text: &#34;describe a completely reconstituted in vitro assay for M5GN2-PP-Dol translocation and demonstrate that purified Rft1 catalyzes the translocation of M5GN2-PP-Dol across the lipid bilayer.&#34;
      - reference_id: file:human/RFT1/RFT1-deep-research-falcon.md
        supporting_text: &#34;Purified human RFT1 directly catalyzes the transbilayer movement of M5GN2-PP-Dol&#34;
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: &gt;-
      IEA annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping.
      This is consistent with the more specific IBA annotation and direct experimental
      evidence from PMID:18313027.
    action: ACCEPT
    reason: &gt;-
      While this is a computational annotation, it correctly reflects the established
      ER membrane localization of RFT1 and is consistent with experimental evidence.
    supported_by:
      - reference_id: PMID:18313027
        supporting_text: &#34;RFT1 deficiency in both yeast and human cells leads to the accumulation of incomplete DolPP-GlcNAc(2)Man(5) and to a profound glycosylation disorder in humans.&#34;
- term:
    id: GO:0006488
    label: dolichol-linked oligosaccharide biosynthetic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: &gt;-
      IEA annotation based on InterPro domain mapping (IPR007594). RFT1 participates
      in dolichol-linked oligosaccharide biosynthesis by translocating the M5GN2-PP-Dol
      intermediate to enable lumenal elongation to the mature Glc3Man9GlcNAc2-PP-Dol
      precursor.
    action: ACCEPT
    reason: &gt;-
      This process annotation is accurate. RFT1 functions in LLO biosynthesis by
      catalyzing the essential translocation step that allows completion of the
      oligosaccharide assembly in the ER lumen. Without RFT1 function, LLO biosynthesis
      is blocked at the M5GN2 stage.
    supported_by:
      - reference_id: PMID:18313027
        supporting_text: &#34;N-linked glycosylation is an essential posttranslational modification of proteins in eukaryotes. The substrate of N-linked glycosylation, dolichol pyrophosphate (DolPP)-GlcNAc(2)Man(9)Glc(3), is assembled through a complex series of ordered reactions requiring the translocation of the intermediate DolPP-GlcNAc(2)Man(5) structure across the endoplasmic-reticulum membrane.&#34;
      - reference_id: PMID:38886340
        supporting_text: &#34;studies identified Rft1 as the M5GN2-PP-Dol flippase in vivo but are at odds with biochemical data suggesting Rft1 is dispensable for flipping in vitro.&#34;
- term:
    id: GO:0016020
    label: membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: &gt;-
      IEA annotation for general membrane localization based on InterPro domain mapping.
      This is accurate but less specific than the ER membrane annotations.
    action: KEEP_AS_NON_CORE
    reason: &gt;-
      While technically correct (RFT1 is a membrane protein), this annotation is
      overly general. The more specific GO:0005789 (endoplasmic reticulum membrane)
      annotations better capture the actual localization. Retained as it does not
      conflict with more specific annotations.
    supported_by:
      - reference_id: file:human/RFT1/RFT1-deep-research-falcon.md
        supporting_text: &#34;Human RFT1 localizes throughout the ER. DeepTMHMM and experimental tagging/topology mapping indicate ~14 transmembrane spans&#34;
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32296183
  review:
    summary: &gt;-
      IPI annotation from the HuRI (Human Reference Interactome) high-throughput
      yeast two-hybrid screen. RFT1 was found to interact with multiple proteins
      in this systematic binary protein interactome mapping study.
    action: REMOVE
    reason: &gt;-
      The generic &#34;protein binding&#34; term is uninformative for GO annotation purposes,
      as it does not specify the functional consequence of these interactions.
      Furthermore, these high-throughput Y2H interactions lack validation for
      functional relevance to RFT1&#39;s core flippase activity. None of these
      interactors have established roles in the N-glycosylation or LLO translocation
      pathway. Following GO curation guidelines, generic protein binding annotations
      should be avoided when more specific molecular function terms are available.
    additional_reference_ids:
      - UniProt:Q96AA3
- term:
    id: GO:0034202
    label: glycolipid floppase activity
  evidence_type: IDA
  original_reference_id: PMID:38886340
  review:
    summary: &gt;-
      IDA annotation for glycolipid floppase activity based on the landmark 2024 Chen et al.
      study that demonstrated direct flippase activity using purified protein in reconstituted
      proteoliposomes. The study showed that purified Rft1 catalyzes the translocation of
      M5GN2-PP-Dol/Phy across lipid bilayers with high efficiency (~90% conversion to
      mannosidase-accessible product within 2 hours) and substrate selectivity for M5
      over M3 intermediates.
    action: ACCEPT
    reason: &gt;-
      This is the definitive molecular function annotation for RFT1. The 2024 reconstitution
      studies resolved the longstanding controversy about whether RFT1 directly catalyzes
      translocation or acts indirectly. Purified protein was shown to be necessary and
      sufficient for flippase activity, establishing this as the core molecular function.
    supported_by:
      - reference_id: PMID:38886340
        supporting_text: &#34;describe a completely reconstituted in vitro assay for M5GN2-PP-Dol translocation and demonstrate that purified Rft1 catalyzes the translocation of M5GN2-PP-Dol across the lipid bilayer.&#34;
      - reference_id: PMID:38886340
        supporting_text: &#34;Rft1 is specific for M5GN2-PP-Dol translocation&#34;
- term:
    id: GO:0034203
    label: glycolipid translocation
  evidence_type: IDA
  original_reference_id: PMID:38886340
  review:
    summary: &gt;-
      IDA annotation for glycolipid translocation based on the same 2024 Chen et al.
      reconstitution study. This biological process annotation complements the molecular
      function annotation (GO:0034202) by capturing the process outcome of the flippase
      activity.
    action: ACCEPT
    reason: &gt;-
      Glycolipid translocation is the core biological process function demonstrated
      experimentally. The IDA evidence from reconstituted proteoliposome assays
      provides definitive proof that RFT1 mediates this process.
    supported_by:
      - reference_id: PMID:38886340
        supporting_text: &#34;Purified Rft1 and HhAgl23 translocate lipid-linked M5GN2 intermediate across the lipid bilayer&#34;
      - reference_id: file:human/RFT1/RFT1-deep-research-falcon.md
        supporting_text: &#34;Direct flipping of M5GN2-PP-Dol/Phy by purified Rft1 in proteoliposomes with mannosidase-coupled UPLC-MS readout&#34;
- term:
    id: GO:0034202
    label: glycolipid floppase activity
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-4570573
  review:
    summary: &gt;-
      TAS annotation from Reactome pathway &#34;Defective RFT1 does not flip the N-glycan
      precursor&#34; (R-HSA-4570573). This annotation is based on traceable author statements
      in the literature supporting RFT1&#39;s role as a flippase in the N-glycosylation pathway.
    action: ACCEPT
    reason: &gt;-
      This annotation is consistent with the established molecular function of RFT1
      and is supported by both genetic (PMID:18313027) and biochemical (PMID:38886340)
      evidence. Reactome accurately captures this pathway role.
    supported_by:
      - reference_id: PMID:18313027
        supporting_text: &#34;The human RFT1 protein shares 22% identity with its yeast ortholog, which is involved in the translocation of DolPP-GlcNAc(2)Man(5) from the cytosolic into the lumenal side of the endoplasmic reticulum.&#34;
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: IGI
  original_reference_id: PMID:18313027
  review:
    summary: &gt;-
      IGI annotation based on genetic interaction evidence from the 2008 Haeuptle et al.
      study. Human RFT1 was shown to complement yeast delta-rft1 cells, demonstrating
      functional orthology and implying shared ER membrane localization.
    action: ACCEPT
    reason: &gt;-
      The genetic complementation evidence strongly supports ER membrane localization,
      as the human protein functions in the same cellular compartment and pathway as
      the yeast ortholog.
    supported_by:
      - reference_id: PMID:18313027
        supporting_text: &#34;Despite the low sequence similarity between the yeast and the human RFT1 proteins, we demonstrated both their functional orthology and the pathologic effect of the human p.R67C mutation by complementation assay in Deltarft1 yeast cells.&#34;
- term:
    id: GO:0006487
    label: protein N-linked glycosylation
  evidence_type: IMP
  original_reference_id: PMID:18313027
  review:
    summary: &gt;-
      IMP annotation for protein N-linked glycosylation based on mutant phenotype
      analysis in RFT1-CDG patient cells. Loss of RFT1 function leads to hypoglycosylation
      of proteins, demonstrating its essential role in the N-glycosylation pathway.
    action: ACCEPT
    reason: &gt;-
      This is a well-supported core function annotation. RFT1 is essential for
      N-glycosylation because it translocates the LLO intermediate required for
      lumenal completion of the glycan precursor. Patient cells show accumulation
      of M5GN2-PP-Dol and hypoglycosylation of proteins.
    supported_by:
      - reference_id: PMID:18313027
        supporting_text: &#34;A young patient diagnosed with a congenital disorder of glycosylation characterized by an intracellular accumulation of DolPP-GlcNAc(2)Man(5) was found to carry a homozygous point mutation in the RFT1 gene.&#34;
      - reference_id: PMID:18313027
        supporting_text: &#34;The causality of the RFT1 p.R67C mutation was further established by restoration of normal glycosylation profiles in patient-derived fibroblasts after lentiviral expression of a normal RFT1 cDNA.&#34;
- term:
    id: GO:0006488
    label: dolichol-linked oligosaccharide biosynthetic process
  evidence_type: IMP
  original_reference_id: PMID:18313027
  review:
    summary: &gt;-
      IMP annotation for dolichol-linked oligosaccharide biosynthetic process based
      on mutant phenotype analysis. RFT1-deficient cells accumulate M5GN2-PP-Dol
      and fail to produce the mature LLO precursor, demonstrating the essential
      role of RFT1 in this biosynthetic pathway.
    action: ACCEPT
    reason: &gt;-
      RFT1 is directly involved in LLO biosynthesis by enabling translocation of
      the intermediate to the ER lumen for completion. This is a core process
      annotation with strong IMP evidence.
    supported_by:
      - reference_id: PMID:18313027
        supporting_text: &#34;RFT1 deficiency in both yeast and human cells leads to the accumulation of incomplete DolPP-GlcNAc(2)Man(5) and to a profound glycosylation disorder in humans.&#34;
- term:
    id: GO:0034203
    label: glycolipid translocation
  evidence_type: IGI
  original_reference_id: PMID:18313027
  review:
    summary: &gt;-
      IGI annotation for glycolipid translocation based on genetic interaction
      evidence from yeast complementation studies. Human RFT1 complements yeast
      Rft1 function in glycolipid translocation.
    action: ACCEPT
    reason: &gt;-
      This annotation captures the core biological process function of RFT1
      based on genetic interaction evidence. The complementation studies
      demonstrate functional conservation of the translocation activity.
    supported_by:
      - reference_id: PMID:18313027
        supporting_text: &#34;The definition of the RFT1 defect establishes the functional conservation of the DolPP-GlcNAc(2)Man(5) translocation process in eukaryotes.&#34;
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-4570573
  review:
    summary: &gt;-
      TAS annotation from Reactome for ER membrane localization. This is consistent
      with the established localization from multiple experimental sources and
      computational predictions.
    action: ACCEPT
    reason: &gt;-
      ER membrane localization is well-established and this TAS annotation is
      consistent with experimental evidence. RFT1 functions as an integral ER
      membrane protein in the N-glycosylation pathway.
    supported_by:
      - reference_id: PMID:18313027
        supporting_text: &#34;The human RFT1 protein shares 22% identity with its yeast ortholog, which is involved in the translocation of DolPP-GlcNAc(2)Man(5) from the cytosolic into the lumenal side of the endoplasmic reticulum.&#34;
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO terms
  findings:
    - statement: InterPro domain IPR007594 (RFT1) infers membrane localization and role in LLO biosynthesis
      supporting_text: Gene Ontology annotation through association of InterPro records with GO terms
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings:
    - statement: IBA annotations for ER membrane localization and glycolipid translocation based on PANTHER
      supporting_text: Annotation inferences using phylogenetic trees
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping
  findings:
    - statement: IEA annotation for ER membrane based on UniProt subcellular location data
      supporting_text: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping
- id: PMID:18313027
  title: Human RFT1 deficiency leads to a disorder of N-linked glycosylation.
  findings:
    - statement: Identified RFT1 mutations as cause of CDG type 1N
      supporting_text: A young patient diagnosed with a congenital disorder of glycosylation characterized by an intracellular accumulation of DolPP-GlcNAc(2)Man(5) was found to carry a homozygous point mutation in the RFT1 gene.
    - statement: Demonstrated functional orthology between human and yeast RFT1 via complementation
      supporting_text: Despite the low sequence similarity between the yeast and the human RFT1 proteins, we demonstrated both their functional orthology and the pathologic effect of the human p.R67C mutation by complementation assay in Deltarft1 yeast cells.
    - statement: Patient cells accumulate M5GN2-PP-Dol intermediate due to RFT1 deficiency
      supporting_text: RFT1 deficiency in both yeast and human cells leads to the accumulation of incomplete DolPP-GlcNAc(2)Man(5) and to a profound glycosylation disorder in humans.
    - statement: Causality established by rescue of patient fibroblasts with wild-type RFT1
      supporting_text: The causality of the RFT1 p.R67C mutation was further established by restoration of normal glycosylation profiles in patient-derived fibroblasts after lentiviral expression of a normal RFT1 cDNA.
    - statement: RFT1 mediates translocation of M5GN2-PP-Dol to ER lumen
      supporting_text: The human RFT1 protein shares 22% identity with its yeast ortholog, which is involved in the translocation of DolPP-GlcNAc(2)Man(5) from the cytosolic into the lumenal side of the endoplasmic reticulum.
- id: PMID:32296183
  title: A reference map of the human binary protein interactome.
  findings:
    - statement: High-throughput Y2H study (HuRI) identifying RFT1 protein-protein interactions
      supporting_text: &#34;Here we present a human &#39;all-by-all&#39; reference interactome map of human binary protein interactions, or &#39;HuRI&#39;.&#34;
    - statement: Interactions detected with various proteins but functional relevance to RFT1 core function not established
      supporting_text: Global insights into cellular organization and genome function require comprehensive understanding of the interactome networks
- id: PMID:38886340
  title: Rft1 catalyzes lipid-linked oligosaccharide translocation across the ER membrane.
  findings:
    - statement: Purified Rft1 directly catalyzes M5GN2-PP-Dol translocation across membranes
      supporting_text: describe a completely reconstituted in vitro assay for M5GN2-PP-Dol translocation and demonstrate that purified Rft1 catalyzes the translocation of M5GN2-PP-Dol across the lipid bilayer.
    - statement: Demonstrated substrate selectivity for M5 over M3 intermediates
      supporting_text: Rft1 is specific for M5GN2-PP-Dol translocation
    - statement: Evolutionary conservation with archaeal ortholog HhAgl23
      supporting_text: Purified Rft1 and HhAgl23 translocate lipid-linked M5GN2 intermediate across the lipid bilayer
- id: Reactome:R-HSA-4570573
  title: Defective RFT1 does not flip the N-glycan precursor
  findings: []
- id: file:human/RFT1/RFT1-deep-research-falcon.md
  title: Deep research on RFT1 function (2024)
  findings:
    - statement: ER localization and topology of human RFT1
      supporting_text: &#34;Human RFT1 localizes throughout the ER. DeepTMHMM and experimental tagging/topology mapping indicate ~14 transmembrane spans with both N- and C-termini facing the cytosol&#34;
    - statement: 2024 biochemical evidence for direct flippase activity
      supporting_text: &#34;Purified human RFT1 directly catalyzes the transbilayer movement of M5GN2-PP-Dol&#34;
core_functions:
- description: &gt;-
    Glycolipid floppase activity - catalyzes translocation of Man5GlcNAc2-PP-dolichol
    from cytosolic to lumenal leaflet of the ER membrane, enabling completion of LLO
    biosynthesis for N-glycosylation.
  molecular_function:
    id: GO:0034202
    label: glycolipid floppase activity
  supported_by:
    - reference_id: PMID:38886340
      supporting_text: &#34;describe a completely reconstituted in vitro assay for M5GN2-PP-Dol translocation and demonstrate that purified Rft1 catalyzes the translocation of M5GN2-PP-Dol across the lipid bilayer.&#34;
    - reference_id: PMID:18313027
      supporting_text: &#34;The human RFT1 protein shares 22% identity with its yeast ortholog, which is involved in the translocation of DolPP-GlcNAc(2)Man(5) from the cytosolic into the lumenal side of the endoplasmic reticulum.&#34;
  directly_involved_in:
    - id: GO:0034203
      label: glycolipid translocation
    - id: GO:0006488
      label: dolichol-linked oligosaccharide biosynthetic process
    - id: GO:0006487
      label: protein N-linked glycosylation
  locations:
    - id: GO:0005789
      label: endoplasmic reticulum membrane
</code></pre>
            </div>
        </details>
    </div>

    <!-- Pathway Visualization Link -->
    

    <style>
        /* Markdown Section Styles */
        .markdown-section {
            margin-bottom: 1rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .markdown-section summary {
            cursor: pointer;
            user-select: none;
        }

        .markdown-section summary h3 {
            margin: 0;
            color: #495057;
            font-size: 1.1rem;
        }

        .markdown-section summary:hover h3 {
            color: #007bff;
        }

        .markdown-section[open] {
            background-color: #fff;
        }

        .markdown-content {
            margin-top: 1rem;
            padding: 1rem;
            border-top: 1px solid #dee2e6;
        }

        /* Markdown content styling */
        .markdown-content h1 { font-size: 1.5rem; margin-top: 1.5rem; }
        .markdown-content h2 { font-size: 1.3rem; margin-top: 1.3rem; }
        .markdown-content h3 { font-size: 1.1rem; margin-top: 1.1rem; }
        .markdown-content h4 { font-size: 1rem; margin-top: 1rem; }

        .markdown-content pre {
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .markdown-content code {
            background-color: #f8f9fa;
            padding: 0.2rem 0.4rem;
            border-radius: 3px;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
        }

        .markdown-content pre code {
            background: none;
            padding: 0;
        }

        .markdown-content table {
            border-collapse: collapse;
            width: 100%;
            margin: 1rem 0;
        }

        .markdown-content table th,
        .markdown-content table td {
            border: 1px solid #dee2e6;
            padding: 0.5rem;
            text-align: left;
        }

        .markdown-content table th {
            background-color: #f8f9fa;
            font-weight: bold;
        }

        .markdown-content blockquote {
            border-left: 4px solid #007bff;
            padding-left: 1rem;
            margin-left: 0;
            color: #666;
        }

        /* YAML Preview Styles */
        .yaml-preview {
            margin-top: 2rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .yaml-preview summary {
            cursor: pointer;
            user-select: none;
        }

        .yaml-preview summary h2 {
            margin: 0;
            color: #495057;
            font-size: 1.3rem;
        }

        .yaml-preview summary:hover h2 {
            color: #007bff;
        }

        .yaml-preview[open] {
            background-color: #fff;
        }

        .yaml-content {
            margin-top: 1rem;
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .yaml-content pre {
            margin: 0;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
            line-height: 1.4;
        }

        .yaml-content code {
            color: #333;
            background: none;
            padding: 0;
        }

        /* Pathway Link Styles */
        .pathway-link {
            margin: 1rem 0;
        }

        .btn-link {
            display: inline-block;
            padding: 0.5rem 1rem;
            background-color: #007bff;
            color: white !important;
            text-decoration: none;
            border-radius: 4px;
            font-weight: 500;
            transition: background-color 0.2s;
        }

        .btn-link:hover {
            background-color: #0056b3;
            text-decoration: none;
        }

        /* Voting buttons */
        .vote-buttons {
            display: inline-block;
            margin-left: 0.5rem;
        }

        .vote-btn {
            background: none;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 2px 6px;
            margin: 0 2px;
            cursor: pointer;
            font-size: 0.9rem;
            transition: all 0.2s;
            opacity: 0.6;
        }

        .vote-btn:hover {
            opacity: 1;
            transform: scale(1.1);
        }

        .vote-btn.voted {
            opacity: 1;
            border-color: #28a745;
            background-color: #d4edda;
        }

        .vote-btn.voted-down {
            border-color: #dc3545;
            background-color: #f8d7da;
        }
    </style>

    <script>
        // Add collapsible functionality
        document.querySelectorAll('.collapsible').forEach(element => {
            element.addEventListener('click', function() {
                this.classList.toggle('collapsed');
            });
        });

        // Voting functionality
        const VOTE_URL = 'https://script.google.com/macros/s/AKfycbwPKH7d3seuPNBtB0ugVjqGeTiByyOGD5vkqB_Ck6K8eOcPQYbJqBOuz6GFgXHKBNWK/exec';

        // Get or create session ID
        let sessionId = localStorage.getItem('review_session_id');
        if (!sessionId) {
            sessionId = 's' + Date.now() + '_' + Math.random().toString(36).substr(2, 9);
            localStorage.setItem('review_session_id', sessionId);
        }

        // Show previous votes on page load
        document.addEventListener('DOMContentLoaded', function() {
            document.querySelectorAll('.vote-buttons').forEach(container => {
                const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
                const previousVote = localStorage.getItem(key);
                if (previousVote) {
                    const btn = container.querySelector(`[data-v="${previousVote}"]`);
                    if (btn) btn.classList.add(previousVote === 'up' ? 'voted' : 'voted-down');
                }
            });
        });

        // Handle vote clicks - Simple image beacon approach
        document.addEventListener('click', function(e) {
            if (!e.target.classList.contains('vote-btn')) return;

            // Prevent the click from bubbling to parent elements (like summary)
            e.preventDefault();
            e.stopPropagation();

            const btn = e.target;
            const container = btn.closest('.vote-buttons');
            if (!container) return;

            const voteType = btn.dataset.v;

            // Check if already voted (locally)
            const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
            const previousVote = localStorage.getItem(key);

            if (previousVote === voteType) {
                // Same vote - do nothing
                btn.style.animation = 'shake 0.5s';
                setTimeout(() => btn.style.animation = '', 500);
                return;
            }

            // Build URL
            const params = new URLSearchParams({
                gene_id: container.dataset.g,
                annotation_id: container.dataset.a,
                ref_id: container.dataset.r || '',
                action: container.dataset.act,
                vote: voteType,
                session_id: sessionId,
                ua: navigator.userAgent.substring(0, 100)
            });

            // Clear previous vote styling
            container.querySelectorAll('.vote-btn').forEach(b => {
                b.classList.remove('voted', 'voted-down');
            });

            // Apply new vote styling immediately (optimistic UI)
            btn.classList.add(voteType === 'up' ? 'voted' : 'voted-down');

            // Store locally
            localStorage.setItem(key, voteType);

            // Send vote using fetch with no-cors mode (fire and forget)
            const fullUrl = VOTE_URL + '?' + params;
            console.log('Sending vote to:', fullUrl);

            // Use fetch in no-cors mode - we won't get a response but the request will be sent
            fetch(fullUrl, {
                mode: 'no-cors',
                method: 'GET'
            }).then(() => {
                console.log('Vote request sent (no response due to no-cors mode)');
            }).catch(err => {
                console.warn('Vote may not have been recorded, but saved locally:', err);

                // Fallback: try image beacon as well
                const img = new Image();
                img.src = fullUrl;
            });
        });

        // Optional: Add shake animation for feedback
        const style = document.createElement('style');
        style.textContent = `
            @keyframes shake {
                0%, 100% { transform: translateX(0); }
                25% { transform: translateX(-5px); }
                75% { transform: translateX(5px); }
            }
        `;
        document.head.appendChild(style);
    </script>
</body>
</html>